X Financial XYF Financial Statement Data


2025 Q2

Submissions

Field Row 1
adsh 0001410578-25-000892
cik 1725033
name X FINANCIAL
sic 6199
countryba CN
stprba
cityba SHENZHEN
zipba 518067
bas1 7-8F,BLOCK A,AEROSPACE SCIENCE&TECH PLZ
bas2 NO. 168 HAIDE THIRD AVENUE, NANSHAN DIST
baph 86-0755-86282977
countryma CN
stprma
cityma SHENZHEN
zipma 518067
mas1 7-8F,BLOCK A,AEROSPACE SCIENCE&TECH PLZ
mas2 NO. 168 HAIDE THIRD AVENUE, NANSHAN DIST
countryinc KY
stprinc
ein 000000000
former
changed
afs 2-ACC
wksi 0
fye 1231
form 20-F
period 20241231
fy 2024
fp FY
filed 20250425
accepted 2025-04-25 06:06:00.0
prevrpt 0
detail 1
instance xyf-20241231x20f_htm.xml
nciks 1
aciks

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
cik Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings.
name Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date.
sic Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business.
countryba The ISO 3166-1 country of the registrant's business address.
stprba The state or province of the registrant’s business address, if field countryba is US or CA.
cityba The city of the registrant's business address.
zipba The zip code of the registrant’s business address.
bas1 The first line of the street of the registrant’s business address.
bas2 The second line of the street of the registrant’s business address.
baph The phone number of the registrant’s business address.
countryma The ISO 3166-1 country of the registrant's mailing address.
stprma The state or province of the registrant’s mailing address, if field countryma is US or CA.
cityma The city of the registrant's mailing address.
zipma The zip code of the registrant’s mailing address.
mas1 The first line of the street of the registrant’s mailing address.
mas2 The second line of the street of the registrant’s mailing address.
countryinc The ISO 3166-1 country of incorporation for the registrant.
stprinc The state or province of incorporation for the registrant, if countryinc is US or CA.
ein Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States.
former Most recent former name of the registrant, if any.
changed Date of change from the former name, if any.
afs Filer status with the SEC at the time of submission:
1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned.
wksi Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement.
fye Fiscal Year End Date, rounded to nearest month-end.
form The submission type of the registrant’s filing.
period Balance Sheet Date, rounded to nearest month-end.
fy Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8).
fp Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year.
filed The date of the registrant’s filing with the Commission.
accepted The acceptance date and time of the registrant’s filing with the Commission.
prevrpt Previous Report – TRUE indicates that the submission information was subsequently amended.
detail TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount).
instance The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol.
nciks Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing.
aciks Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information.

Numbers

adsh ddate tag value uom qtrs version segments coreg footnote
0001410578-25-000892 20231231 Accounts Receivable And Contract Assets Net 83535036.0000 CNY 0 0001410578-25-000892 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 2029550471.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 58991579.0000 CNY 0 0001410578-25-000892 Product Or Service= Service Other;
0001410578-25-000892 20241231 Accrued Income Taxes 591491126.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Accrued Income Taxes 81033952.0000 USD 0 us-gaap/2024
0001410578-25-000892 20231231 Accrued Liabilities And Other Liabilities 575727263.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Accrued Liabilities And Other Liabilities 127339668.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Accrued Liabilities And Other Liabilities 2511920.0000 USD 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax 11104082.0000 USD 0 us-gaap/2024
0001410578-25-000892 20231231 Additional Paid In Capital 3196942284.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 53537815.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 53537815.0000 CNY 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 5504337.0000 USD 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Allowance For Doubtful Accounts Receivable And Contract Assets 24172284.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20240930 Assets 430967257.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001410578-25-000892 20241231 Assets 865478216.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20231231 Cash And Cash Equivalents At Carrying Value 156369105.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1359623.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents After Allowance Of Credit Losses 1661404820.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 157268.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Changes In Fair Value Of Loans And Payable To Investors 0.0000 CNY 4 0001410578-25-000892 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001410578-25-000892 20231231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Common Stock Par Or Stated Value Per Share 0.0001 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Common Stock Shares Outstanding 250678439.0000 shares 0 us-gaap/2024
0001410578-25-000892 20221231 Comprehensive Income Net Of Tax 869285476.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Comprehensive Income Net Of Tax 1192672034.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Comprehensive Income Net Of Tax 212552045.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Deferred Income Tax Liabilities Net 642602.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Deposit Assets 1958297244.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20221231 Depreciation Depletion And Amortization 6646312.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Derivative Assets 0.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Derivative Assets 0.0000 CNY 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001410578-25-000892 20231231 Dividends Common Stock 117627440.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Dividends Common Stock 57413424.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Dividends Common Stock 7865607.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001410578-25-000892 20231231 Dividends Payable Current And Noncurrent 59226084.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Dividends Payable Current And Noncurrent 0.0000 USD 0 us-gaap/2024
0001410578-25-000892 20221231 Earnings Per Share Diluted 2.5200 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Earnings Per Share Diluted 5.2500 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Financial Investment 5313961988.0000 CNY 0 0001410578-25-000892 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20241231 Financial Investment 70345860.0000 USD 0 0001410578-25-000892
0001410578-25-000892 20211231 Financing Receivable Allowance For Credit Losses 55335741.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20221231 Financing Receivable Allowance For Credit Losses 103630827.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20231231 Financing Receivable Allowance For Credit Losses 0.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 0.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20241231 Gain Loss On Investments 17133677.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Gain Loss On Sale Of Property Plant Equipment -148198.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Gain Loss On Sale Of Property Plant Equipment 7712.0000 USD 4 us-gaap/2024
0001410578-25-000892 20221231 General And Administrative Expense 171500000.0000 CNY 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001410578-25-000892 20231231 Guarantees Fair Value Disclosure 61906509.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20231231 Guarantees Fair Value Disclosure 8481157.0000 USD 0 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20241231 Guarantees Fair Value Disclosure 187640702.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20221231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments -17758020.0000 CNY 4 us-gaap/2024 Geographical= H K;
0001410578-25-000892 20231231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 65500000.0000 CNY 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001410578-25-000892 20231231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 1403100000.0000 CNY 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001410578-25-000892 20241231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 1614831.0000 USD 4 us-gaap/2024 Geographical= H K;
0001410578-25-000892 20241231 Income Loss From Equity Method Investments 1391782.0000 USD 4 us-gaap/2024
0001410578-25-000892 20231231 Income Taxes Paid Net 102284875.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Increase Decrease From Collection Of Trading Financial Investment 1402600.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20231231 Increase Decrease From Purchase Of Trading Financial Investment 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease In Accounts Receivable And Contract Assets 405694629.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease In Accounts Receivable And Contract Assets 55579936.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20231231 Increase Decrease In Accrued Income Taxes Payable 176410814.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Increase Decrease In Accrued Income Taxes Payable 143866349.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Increase Decrease In Deposit Payable -7683820.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Increase Decrease In Employee Related Liabilities 23089279.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Increase Decrease In Other Noncurrent Assets 121124.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Increase Decrease In Prepaid Deferred Expense And Other Assets -1961150.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Intangible Assets Net Excluding Goodwill 5013079.0000 USD 0 us-gaap/2024
0001410578-25-000892 20231231 Interest Income Expense Nonoperating Net -20364821.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20230930 Liabilities 2001575.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001410578-25-000892 20231231 Liabilities 3631701484.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20231231 Liabilities 59831073.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Liabilities 666657756.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Liabilities 302177755.0000 USD 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Liabilities 922756878.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20241231 Liabilities And Stockholders Equity 1619236036.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Loans And Leases Receivables Net Reported Amount 4828316995.0000 CNY 0 0001410578-25-000892 Major Products= Xiaoying Credit Loans And Revolving Loans;
0001410578-25-000892 20241231 Loans Payable To Institutional Funding Partners 299218510.0000 USD 0 0001410578-25-000892 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20231231 Long Term Investments 493411355.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20231231 Long Term Investments 527245707.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20221231 Net Cash Provided By Used In Financing Activities 576351240.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Net Cash Provided By Used In Investing Activities 304100000.0000 CNY 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001410578-25-000892 20231231 Net Cash Provided By Used In Investing Activities -1683641707.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Net Cash Provided By Used In Investing Activities 664702231.0000 CNY 4 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Net Cash Provided By Used In Investing Activities -106448449.0000 CNY 4 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20221231 Net Cash Provided By Used In Operating Activities 322700000.0000 CNY 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001410578-25-000892 20231231 Net Cash Provided By Used In Operating Activities 172210364.0000 CNY 4 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Net Income Loss 85482852.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Net Income Loss 16451951.0000 USD 4 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20231231 Net Income Loss Attributable To Noncontrolling Interest 0.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Net Income Loss Attributable To Noncontrolling Interest 0.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Oci Equity Method Investment After Tax Parent -313815.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Oci Equity Method Investment After Tax Parent -42992.0000 USD 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20221231 Operating Income Loss 1213779602.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Other Assets Noncurrent 21976.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Other Assets Noncurrent 3019189760.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20241231 Other Assets Noncurrent 6158325.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 292799.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 40113.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Other Liabilities Noncurrent 293682.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20231231 Other Nonoperating Income Expense 2166066.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Payments To Acquire Property Plant And Equipment 6055110.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Payments To Acquire Property Plant And Equipment 1948559.0000 USD 4 us-gaap/2024
0001410578-25-000892 20221231 Payments To Fund Short Term Loans To Related Parties -164707863.0000 CNY 4 0001410578-25-000892 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Payment To Investors Of Consolidated Trusts At Fair Value 1335158227.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Payment To Investors Of Consolidated Trusts At Fair Value 2295866494.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Prepaid Expense And Other Assets Current 2670289.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Prepaid Expense And Other Assets Current 89962974.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20241231 Proceeds From Collection Of Loans Earnings Rights From Related Party 0.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20241231 Proceeds From Collection Of Loans Receivable 0.0000 USD 4 us-gaap/2024 Consolidated Entities= Partnership Interest;
0001410578-25-000892 20221231 Profit Loss 811996439.0000 CNY 4 us-gaap/2024 Equity Components= Retained Earnings;
0001410578-25-000892 20231231 Profit Loss 1186793974.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Profit Loss 1539905765.0000 CNY 4 us-gaap/2024 Equity Components= Retained Earnings;
0001410578-25-000892 20231231 Property Plant And Equipment Net 1054565.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Property Plant And Equipment Net 15833490.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Provision For Accounts Receivable And Contract Assets 12233743.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Provision For Contingent Guarantee Liabilities 67519980.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Provision For Contingent Guarantee Liabilities 241738132.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Provision For Loan Losses Expensed -2737290.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Revolving Loan;
0001410578-25-000892 20241231 Provision For Loan Losses Expensed 225815327.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Provision For Loans Receivable During Period And Other Loans 164641879.0000 CNY 4 0001410578-25-000892 Major Products= Xiaoying Credit Loans And Revolving Loans;
0001410578-25-000892 20241231 Provision For Loans Receivable During Period And Other Loans 30936573.0000 USD 4 0001410578-25-000892 Major Products= Xiaoying Credit Loans And Revolving Loans;
0001410578-25-000892 20231231 Restricted Cash Current 711756581.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts And Partnerships;
0001410578-25-000892 20231231 Restricted Cash Current 716870052.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Restricted Cash Current 72966430.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20231231 Restricted Cash Current Before Allowance Of Credit Losses 749155845.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20231231 Retained Earnings Accumulated Deficit 2692018850.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Loan Products; Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Loan Products; Product Or Service= Post Origination Service;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 2044343554.0000 CNY 4 us-gaap/2024 Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 179878489.0000 CNY 4 us-gaap/2024 Product Or Service= Service Other;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Loan Products; Product Or Service= Post Origination Service;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 283032373.0000 CNY 4 us-gaap/2024 Major Products= Other Services;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 283032373.0000 CNY 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Service Other;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 24496658.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Guarantees;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Guarantees;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Product Or Service= Post Origination Service; Related Party Transactions By Related Party= Related Party;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 804430801.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 54518856.0000 USD 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Service Other;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 27634950.0000 USD 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Guarantees;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 59756181.0000 USD 4 us-gaap/2024 Product Or Service= Service Other;
0001410578-25-000892 20231231 Short Term Borrowings 320000000.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Short Term Borrowings 1369994.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -111520291.0000 CNY 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001410578-25-000892 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 379162925.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001410578-25-000892 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4174511191.0000 CNY 0 us-gaap/2024 Equity Components= Retained Earnings;
0001410578-25-000892 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 952578280.0000 USD 0 us-gaap/2024
0001410578-25-000892 20231231 Transfer Of Investments 13968313.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Treasury Stock Shares Acquired 5026374.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001410578-25-000892 20231231 Treasury Stock Value 111520291.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Treasury Stock Value 509643763.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Unrealized Gain Loss On Derivatives 142241.0000 USD 4 us-gaap/2024
0001410578-25-000892 20231231 Accounts Receivable And Contract Assets Net 1352649104.0000 CNY 0 0001410578-25-000892 Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 5120113.0000 USD 0 0001410578-25-000892 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 10240802.0000 USD 0 0001410578-25-000892 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Accrual For Taxes Other Than Income Taxes Current And Noncurrent 38359047.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Accrual For Taxes Other Than Income Taxes Current And Noncurrent 447325.0000 USD 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Accrued Liabilities And Other Liabilities 33648051.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Accrued Liabilities And Other Liabilities 716827039.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax 11104082.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 42598210.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 42598210.0000 CNY 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20241231 Allowance For Doubtful Accounts Receivable And Contract Assets 24172284.0000 CNY 0 0001410578-25-000892 Product Or Service= Credit Losses;
0001410578-25-000892 20241231 Allowance For Doubtful Accounts Receivable And Contract Assets 3311589.0000 USD 0 0001410578-25-000892
0001410578-25-000892 20240930 Cash And Cash Equivalents At Carrying Value 3575103.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001410578-25-000892 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1944507575.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 266396446.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 227644599.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 186268.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents After Allowance Of Credit Losses 1944421556.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents After Allowance Of Credit Losses 227611528.0000 USD 0 0001410578-25-000892
0001410578-25-000892 20241231 Cash Paid To Institutional Funding Partners 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Cash Payment Received From Consolidated Trusts At Fair Value 1698154102.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Changes In Fair Value Of Loans And Payable To Investors 0.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20241231 Common Stock Shares Outstanding 250678439.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001410578-25-000892 20241231 Common Stock Value 28331.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Comprehensive Income Net Of Tax 1192672034.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Comprehensive Income Net Of Tax 1551481144.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 0.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 0.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 0.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 1551481144.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Cost Of Revenue 2869800000.0000 CNY 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001410578-25-000892 20241231 Cost Of Revenue 1738139455.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Deferred Guarantee Income Guarantee Obligations 46597143.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20231231 Deferred Guarantee Income Guarantee Obligations 6383782.0000 USD 0 0001410578-25-000892
0001410578-25-000892 20241231 Deferred Income Tax Liabilities Net 9036287.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Derivative Assets 0.0000 CNY 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001410578-25-000892 20241231 Derivative Assets 142241.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Derivative Assets 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001410578-25-000892 20231231 Dividends Payable Current And Noncurrent 59226084.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Earnings Per Share Basic 4.1200 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 131100.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Employee Related Liabilities Current And Noncurrent 12976169.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Employee Related Liabilities Current And Noncurrent 2532092.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20211231 Financing Receivable Allowance For Credit Losses 610684.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Revolving Loan;
0001410578-25-000892 20231231 Financing Receivable Allowance For Credit Losses 188718875.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20231231 Financing Receivable Allowance For Credit Losses 25854459.0000 USD 0 us-gaap/2024
0001410578-25-000892 20231231 Financing Receivable Allowance For Credit Losses 0.0000 USD 0 us-gaap/2024 Major Products= Xiaoying Revolving Loan;
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 18120891.0000 USD 0 us-gaap/2024 Financial Instrument= Loans Facilitated In2024; Major Products= Xiaoying Credit Loans And Other Loans;
0001410578-25-000892 20221231 Foreign Currency Transaction Gain Loss Before Tax -19962949.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Gain Loss On Investments -9525822.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Gain Loss On Sale Of Property Plant Equipment 2678.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Guarantees Fair Value Disclosure 0.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Guarantees Fair Value Disclosure 61906509.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Guarantees Fair Value Disclosure 187640702.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Impairment Losses On Financial Investments 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Impairment Losses On Financial Investments 0.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20221231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments -3600000.0000 CNY 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001410578-25-000892 20231231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments -3703756.0000 CNY 4 us-gaap/2024 Geographical= K Y;
0001410578-25-000892 20241231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 1890138917.0000 CNY 4 us-gaap/2024 Geographical= C N;
0001410578-25-000892 20241231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 259522159.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Income Loss From Equity Method Investments 10159031.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Income Loss From Equity Method Investments 212006867.0000 USD 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Increase Decrease In Accrued Expenses And Other Current Liabilities 114945354.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease In Accrued Income Taxes Payable 19709609.0000 USD 4 us-gaap/2024
0001410578-25-000892 20231231 Increase Decrease In Deferred Guarantee Income 46597143.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20221231 Increase Decrease In Deposit Payable -1312000.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Increase Decrease In Deposits To Institutional Co Operators -68518587.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20221231 Increase Decrease In Derivative Liabilities -223943839.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Increase Decrease In Employee Related Liabilities 1088640.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Increase Decrease In Property And Other Taxes Payable -1346280.0000 USD 4 us-gaap/2024
0001410578-25-000892 20231231 Intangible Assets Net Excluding Goodwill 36810384.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Interest Paid Net 3310297.0000 USD 4 us-gaap/2024
0001410578-25-000892 20231231 Liabilities 5802900353.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Liabilities 2602145884.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Liabilities 356492525.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20231231 Loans And Leases Receivables Net Reported Amount 8656846.0000 CNY 0 0001410578-25-000892 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20241231 Loans Payable To Institutional Funding Partners 2184085667.0000 CNY 0 0001410578-25-000892 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Long Term Investments 498038310.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Long Term Investments 667927748.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20241231 Long Term Investments 91505726.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20231231 Net Cash Provided By Used In Financing Activities 1114841744.0000 CNY 4 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Net Cash Provided By Used In Financing Activities -298721127.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Net Cash Provided By Used In Financing Activities -265118055.0000 USD 4 us-gaap/2024
0001410578-25-000892 20221231 Net Cash Provided By Used In Investing Activities 164707863.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Net Cash Provided By Used In Investing Activities 16718629.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Net Cash Provided By Used In Investing Activities 91063832.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20231231 Net Cash Provided By Used In Operating Activities -5736205.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Net Cash Provided By Used In Operating Activities 550953578.0000 CNY 4 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Net Cash Provided By Used In Operating Activities 75480331.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Net Cash Provided By Used In Operating Activities -1117562.0000 USD 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Net Cash Provided By Used In Operating Activities 207908054.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20221231 Net Income Loss 360550889.0000 CNY 4 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20221231 Net Income Loss 738032308.0000 CNY 4 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20230930 Net Income Loss -40043826.0000 CNY 3 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001410578-25-000892 20231231 Net Income Loss 438091276.0000 CNY 4 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20240930 Net Income Loss 43343090.0000 USD 3 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001410578-25-000892 20241231 Net Income Loss 1539905765.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Oci Equity Method Investment After Tax Parent 204444.0000 CNY 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001410578-25-000892 20231231 Oci Equity Method Investment After Tax Parent -6852.0000 CNY 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001410578-25-000892 20221231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 57084593.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Proceeds From Short Term Debt 133500000.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 11596395.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 1588699.0000 USD 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20231231 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 474792.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Payments For Proceeds From Loans Receivable 4302244495.0000 CNY 4 us-gaap/2024 Consolidated Entities= Shenzhen Xiaoying Microcredit Co. Ltd.; Major Products= Xiaoying Credit Loans And Revolving Loans;
0001410578-25-000892 20221231 Payments For Repurchase Of Common Stock 146740902.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Payments For Repurchase Of Common Stock 182204126.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Payments To Acquire Financial Investments 90539800.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Prepaid Expense And Other Assets Current 466272257.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20221231 Proceeds From Collection Of Financial Investments 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Proceeds From Collection Of Financial Investments 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20221231 Proceeds From Sale And Collection Of Loans Receivable 1706218237.0000 CNY 4 us-gaap/2024 Consolidated Entities= Shenzhen Xiaoying Microcredit Co. Ltd.;
0001410578-25-000892 20231231 Proceeds From Sale And Collection Of Loans Receivable 2360056343.0000 CNY 4 us-gaap/2024 Consolidated Entities= Shenzhen Xiaoying Microcredit Co. Ltd.;
0001410578-25-000892 20231231 Proceeds From Sale Of Longterm Investments 0.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Proceeds From Sale Of Longterm Investments 0.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Proceeds From Sale Of Property Plant And Equipment 14789.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Proceeds From Stock Options Exercised 122507.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Profit Loss 1186793974.0000 CNY 4 us-gaap/2024 Equity Components= Retained Earnings;
0001410578-25-000892 20241231 Profit Loss 1539905765.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20231231 Property Plant And Equipment Net 8642392.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Property Plant And Equipment Net 155931.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20221231 Provision For Loan And Leases Losses -6066176.0000 CNY 4 0001410578-25-000892 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20231231 Provision For Loan And Leases Losses -4213234.0000 CNY 4 0001410578-25-000892 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20231231 Provision For Loan Losses Expensed 233350276.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Provision For Loan Losses Expensed -4156904.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20241231 Provision For Loan Losses Expensed -20503.0000 USD 4 us-gaap/2024 Major Products= Loans;
0001410578-25-000892 20221231 Repayments Of Short Term Debt 166500000.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Repayments Of Short Term Debt 307708800.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Restricted Cash Current 532603866.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 207964.0000 CNY 4 us-gaap/2024 Major Products= Other Loan Products; Product Or Service= Service Other;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 20815986.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Service Other;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 435180.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Revolving Loan; Product Or Service= Post Origination Service;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 372450606.0000 CNY 4 us-gaap/2024 Product Or Service= Post Origination Service;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 1601289.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Housing Loan; Product Or Service= Service Other;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 326706200.0000 CNY 4 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 397949477.0000 CNY 4 us-gaap/2024 Major Products= Other Services;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 201715792.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Guarantees;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 187963789.0000 USD 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Financial Service;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 5237325.0000 USD 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Service Other;
0001410578-25-000892 20221231 Reversal Of Credit Losses For Other Financial Assets -764600.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Share Based Compensation 5504337.0000 USD 4 us-gaap/2024
0001410578-25-000892 20231231 Stockholders Equity 5847124287.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3159522737.0000 CNY 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 1622852316.0000 CNY 0 us-gaap/2024 Equity Components= Retained Earnings;
0001410578-25-000892 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 450279902.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -509643763.0000 CNY 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001410578-25-000892 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 439361088.0000 USD 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20241231 Stock Issued During Period Shares Stock Options Exercised 1991311.0000 shares 4 us-gaap/2024
0001410578-25-000892 20231231 Stock Issued During Period Value Stock Options Exercised 1099619.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Stock Issued During Period Value Stock Options Exercised 1099619.0000 CNY 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20241231 Stock Issued During Period Value Stock Options Exercised 122507.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Stock Issued During Period Value Stock Options Exercised 122507.0000 CNY 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20241231 Stock Issued During Period Value Stock Options Exercised 16783.0000 USD 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20221231 Transfer Of Investments 0.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Transfer To Investments 0.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Treasury Stock Value 509643763.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Treasury Stock Value 69820909.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Treasury Stock Value Acquired Cost Method 146740902.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Treasury Stock Value Acquired Cost Method 24872828.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Treasury Stock Value Acquired Cost Method 58682021.0000 USD 4 us-gaap/2024
0001410578-25-000892 20221231 Weighted Average Number Of Shares Outstanding Basic 316444826.0000 shares 4 us-gaap/2024
0001410578-25-000892 20231231 Accounts Receivable And Contract Assets Net 54749985.0000 CNY 0 0001410578-25-000892 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20231231 Accounts Receivable And Contract Assets Net 58824408.0000 CNY 0 0001410578-25-000892 Product Or Service= Guarantee Income;
0001410578-25-000892 20231231 Accounts Receivable And Contract Assets Net 143392745.0000 CNY 0 0001410578-25-000892 Product Or Service= Post Origination Service;
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 37373243.0000 CNY 0 0001410578-25-000892 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 75973998.0000 CNY 0 0001410578-25-000892 Product Or Service= Financial Service;
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 8081813.0000 USD 0 0001410578-25-000892 Product Or Service= Service Other;
0001410578-25-000892 20231231 Accrued Income Taxes 28266791.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Accrued Liabilities And Other Liabilities 94825511.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Accrued Liabilities And Other Liabilities 5232335603.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20231231 Accumulated Other Comprehensive Income Loss Net Of Tax 69476651.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax 81052030.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Additional Paid In Capital 3196942284.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 42598210.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 5504337.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Allowance For Doubtful Accounts Receivable And Contract Assets 0.0000 CNY 0 0001410578-25-000892 Related Party Transactions By Related Party= Related Party;
0001410578-25-000892 20231231 Assets 6647581573.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Assets 7198761864.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Assets 986226331.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20230930 Cash And Cash Equivalents At Carrying Value 207486569.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001410578-25-000892 20241231 Cash And Cash Equivalents At Carrying Value 580989751.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents After Allowance Of Credit Losses 1006959857.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 21545.0000 USD 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Cash Paid To Institutional Funding Partners 21310352.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Cash Payment Received From Consolidated Trusts At Fair Value 3251997048.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Changes In Fair Value Of Loans And Payable To Investors 531202.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Common Stock Shares Outstanding 293553607.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001410578-25-000892 20241231 Common Stock Value 206793.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Common Stock Value 206793.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 212552045.0000 USD 4 us-gaap/2024
0001410578-25-000892 20231231 Cost Of Revenue 1544013591.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Costs And Expenses 3998012333.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Deferred Guarantee Income Guarantee Obligations 0.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20241231 Deposits 12016415.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Derivative Assets 0.0000 CNY 0 us-gaap/2024 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001410578-25-000892 20241231 Derivative Assets 142241.0000 USD 0 us-gaap/2024 Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001410578-25-000892 20231231 Dividends Common Stock 117627440.0000 CNY 4 us-gaap/2024 Equity Components= Retained Earnings;
0001410578-25-000892 20241231 Dividends Common Stock 57413424.0000 CNY 4 us-gaap/2024 Equity Components= Retained Earnings;
0001410578-25-000892 20241231 Dividends Payable Current And Noncurrent 0.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Earnings Per Share Diluted 4.0800 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Equity Method Investment Dividends Or Distributions 1027496.0000 USD 4 us-gaap/2024
0001410578-25-000892 20231231 Financial Investment 0.0000 CNY 0 0001410578-25-000892 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Financial Investment 4579639.0000 USD 0 0001410578-25-000892 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20231231 Financial Investments At Amortized Cost 406243877.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20231231 Financing Receivable Allowance For Credit Losses 574.0000 CNY 0 us-gaap/2024 Major Products= Loans;
0001410578-25-000892 20231231 Financing Receivable Allowance For Credit Losses 0.0000 USD 0 us-gaap/2024 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 175820629.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 175820629.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20241231 Gain Loss On Sale Of Property Plant Equipment 56293.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 General And Administrative Expense 5899484.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Guarantees Fair Value Disclosure 25706671.0000 USD 0 us-gaap/2024
0001410578-25-000892 20221231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments -5585777.0000 CNY 4 us-gaap/2024 Geographical= K Y;
0001410578-25-000892 20221231 Income Loss From Equity Method Investments -42251538.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Income Taxes Paid Net 289084125.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Income Tax Expense Benefit 261130503.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Increase Decrease From Collection Of Trading Financial Investment 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20221231 Increase Decrease In Accounts Receivable And Contract Assets 436267247.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease In Deferred Guarantee Income 16183383.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20221231 Increase Decrease In Deposits To Institutional Co Operators 271206554.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease In Finance Receivables -12813750.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20231231 Liabilities 4144209019.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Liabilities 245607222.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Liabilities And Stockholders Equity 11650024640.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Liabilities And Stockholders Equity 5906955360.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Liabilities And Stockholders Equity 11819289603.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Loans And Leases Receivables Net Reported Amount 661476716.0000 USD 0 0001410578-25-000892 Major Products= Xiaoying Credit Loans And Revolving Loans;
0001410578-25-000892 20231231 Loans Payable To Institutional Funding Partners 3584040757.0000 CNY 0 0001410578-25-000892 Consolidated Entities= Consolidated Variable Interest Entities Trusts And Partnerships;
0001410578-25-000892 20241231 Long Term Investments 498038310.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20221231 Net Cash Provided By Used In Investing Activities -928400322.0000 CNY 4 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20231231 Net Cash Provided By Used In Investing Activities -673734777.0000 CNY 4 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20231231 Net Cash Provided By Used In Investing Activities 74701887.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Net Cash Provided By Used In Investing Activities 122034285.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Net Cash Provided By Used In Operating Activities 626781729.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Net Cash Provided By Used In Operating Activities 577300000.0000 CNY 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001410578-25-000892 20231231 Net Cash Provided By Used In Operating Activities 814100000.0000 CNY 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001410578-25-000892 20231231 Net Income Loss 1186793974.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Net Income Loss 193845592.0000 CNY 4 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20241231 Net Income Loss 120087725.0000 CNY 4 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20241231 Operating Income Loss 256705357.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 292799.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 40113.0000 USD 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Other Liabilities Noncurrent 27516391.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Other Noncash Income Expense -120025.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Other Nonoperating Income Expense 40723863.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Other Nonoperating Income Expense 3151789.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Other Nonoperating Income Expense 24351280.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Payments For Proceeds From Loans Receivable 2005548657.0000 CNY 4 us-gaap/2024 Consolidated Entities= Shenzhen Xiaoying Microcredit Co. Ltd.; Major Products= Xiaoying Credit Loans And Revolving Loans;
0001410578-25-000892 20241231 Payments Of Dividends 116639508.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Payments To Acquire Financial Investments 424149412.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Payments To Fund Short Term Loans To Related Parties -25848853.0000 USD 4 0001410578-25-000892 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Payment To Investors Of Consolidated Trusts At Fair Value 3098109192.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Proceeds From Collection Of Loans Receivable 0.0000 CNY 4 us-gaap/2024 Consolidated Entities= Partnership Interest;
0001410578-25-000892 20221231 Proceeds From Sale Of Longterm Investments 6852347.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Proceeds From Sale Of Property Plant And Equipment 18053.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Profit Loss 811996439.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Profit Loss 1186793974.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Property Plant And Equipment Net 1138186.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Provision For Accounts Receivable And Contract Assets 35732133.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20221231 Provision For Contingent Guarantee Liabilities -14000000.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20221231 Provision For Loan Losses Expensed 160131434.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20231231 Provision For Loan Losses Expensed 234237584.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20241231 Provision For Loan Losses Expensed -569494.0000 USD 4 us-gaap/2024 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20221231 Restricted Cash Allowance For Credit Loss 0.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20231231 Restricted Cash Current 749069826.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 959446184.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Financial Service;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 2740974233.0000 CNY 4 us-gaap/2024 Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 201715792.0000 CNY 4 us-gaap/2024 Product Or Service= Guarantee Income;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 749911945.0000 USD 4 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 104056367.0000 USD 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Post Origination Service;
0001410578-25-000892 20231231 Reversal Of Provision For Loan And Lease Losses 4213234.0000 CNY 4 0001410578-25-000892 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20241231 Share Based Compensation 40177807.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Short Term Borrowings 565000000.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Short Term Borrowings 328500000.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3976894961.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 69476651.0000 CNY 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001410578-25-000892 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 952578280.0000 USD 0 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20221231 Transfer To Employee Stock Ownership Plans 22144121.0000 CNY 4 0001410578-25-000892 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20241231 Treasury Stock Value Acquired Cost Method 1020543.0000 CNY 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20231231 Unrealized Gain Loss On Derivatives 24966242.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Accrual For Taxes Other Than Income Taxes Current And Noncurrent 126900881.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20231231 Accounts Receivable And Contract Assets Net 1659587975.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20231231 Accounts Receivable And Contract Assets Net 81941166.0000 CNY 0 0001410578-25-000892 Product Or Service= Financial Service;
0001410578-25-000892 20231231 Accounts Receivable And Contract Assets Net 32047171.0000 CNY 0 0001410578-25-000892 Product Or Service= Service Other;
0001410578-25-000892 20231231 Accrual For Taxes Other Than Income Taxes Current And Noncurrent 289821092.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Accrual For Taxes Other Than Income Taxes Current And Noncurrent 279994194.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Accrual For Taxes Other Than Income Taxes Current And Noncurrent 3265159.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Accrual For Taxes Other Than Income Taxes Current And Noncurrent 119683947.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20231231 Accrued Income Taxes 446499777.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Accrued Income Taxes 28266791.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Variable Interest Entities Trusts And Partnerships;
0001410578-25-000892 20231231 Accrued Liabilities And Other Liabilities 43599849.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Accrued Liabilities And Other Liabilities 929490436.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Accrued Liabilities And Other Liabilities 18335260.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Accumulated Other Comprehensive Income Loss Net Of Tax 81052030.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Additional Paid In Capital 3207028391.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Additional Paid In Capital 439361088.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 40177807.0000 CNY 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 40177807.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20231231 Allowance For Doubtful Accounts Financial Investments 0.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20241231 Allowance For Doubtful Accounts Financial Investments 0.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20221231 Allowance For Doubtful Accounts Receivable And Contract Assets 21875166.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20231231 Allowance For Doubtful Accounts Receivable And Contract Assets 9266619.0000 CNY 0 0001410578-25-000892 Product Or Service= Credit Losses;
0001410578-25-000892 20231231 Allowance For Doubtful Accounts Receivable And Contract Assets 1269520.0000 USD 0 0001410578-25-000892
0001410578-25-000892 20231231 Assets 8023906469.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20241231 Assets 6317385140.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -282861357.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Cash Paid To Institutional Funding Partners 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20221231 Common Stock Shares Outstanding 287918569.0000 shares 0 us-gaap/2024 Equity Components= Common Stock;
0001410578-25-000892 20231231 Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest 0.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest 1192672034.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Costs And Expenses 2349170513.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Deferred Income Tax Assets Net 135957626.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Deferred Income Tax Liabilities Net 0.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Variable Interest Entities Trusts And Partnerships;
0001410578-25-000892 20241231 Deposit Assets 268285622.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Depreciation Depletion And Amortization 986228.0000 USD 4 us-gaap/2024
0001410578-25-000892 20221231 Dividend Income From Financial Investments At Equity Method 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Income Taxes Paid Net 39604363.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Dividends Payable Current And Noncurrent 0.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Earnings Per Share Basic 0.7300 USD 4 us-gaap/2024
0001410578-25-000892 20221231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 824099.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 6894284.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 18968.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Employee Related Liabilities Current And Noncurrent 15011080.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Variable Interest Entities Trusts And Partnerships;
0001410578-25-000892 20231231 Employee Related Liabilities Current And Noncurrent 15011080.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20231231 Equity Method Investment Dividends Or Distributions 15000000.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Financing Receivable Allowance For Credit Losses 106479154.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Financing Receivable Allowance For Credit Losses 188719449.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Credit Loans And Revolving Loans;
0001410578-25-000892 20231231 Financing Receivable Allowance For Credit Losses 79.0000 USD 0 us-gaap/2024 Major Products= Loans;
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 0.0000 CNY 0 us-gaap/2024 Major Products= Loans;
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 0.0000 USD 0 us-gaap/2024 Major Products= Xiaoying Revolving Loan;
0001410578-25-000892 20241231 Foreign Currency Transaction Gain Loss Before Tax -9533320.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 General And Administrative Expense 153943169.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 General And Administrative Expense 7502575.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 General And Administrative Expense 1027849.0000 USD 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Impairment Losses On Financial Investments 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments -7595959.0000 CNY 4 us-gaap/2024 Geographical= K Y;
0001410578-25-000892 20241231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 258947970.0000 USD 4 us-gaap/2024 Geographical= C N;
0001410578-25-000892 20221231 Income Loss From Equity Method Investments 817582216.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Increase Decrease In Accrued Expenses And Other Current Liabilities 65114595.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease In Deferred Guarantee Income 118127369.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease In Guarantee Liabilities -116003939.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20221231 Increase Decrease In Other Noncurrent Assets -1562738.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Increase Decrease In Prepaid Deferred Expense And Other Assets -7921314.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Intangible Assets Net Excluding Goodwill 3795773.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Liabilities And Stockholders Equity 7198761864.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Loans And Leases Receivables Net Reported Amount 0.0000 CNY 0 0001410578-25-000892 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20241231 Loans And Leases Receivables Net Reported Amount 0.0000 USD 0 0001410578-25-000892 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20241231 Loans Payable To Institutional Funding Partners 2184085667.0000 CNY 0 0001410578-25-000892 Consolidated Entities= Consolidated Variable Interest Entities Trusts And Partnerships;
0001410578-25-000892 20241231 Loans Payable To Institutional Funding Partners 299218510.0000 USD 0 0001410578-25-000892 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Long Term Investments 68230969.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20221231 Net Cash Provided By Used In Financing Activities 840416352.0000 CNY 4 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20221231 Net Cash Provided By Used In Financing Activities 860416352.0000 CNY 4 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Net Cash Provided By Used In Financing Activities -1399955090.0000 CNY 4 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Net Cash Provided By Used In Financing Activities -1709955090.0000 CNY 4 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20221231 Net Cash Provided By Used In Investing Activities -1217467865.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Net Cash Provided By Used In Investing Activities 42061135.0000 USD 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Net Cash Provided By Used In Operating Activities -9559741.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Net Cash Provided By Used In Operating Activities 628719431.0000 CNY 4 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Net Cash Provided By Used In Operating Activities 1523386291.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20240930 Net Income Loss 316374217.0000 CNY 3 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001410578-25-000892 20241231 Net Income Loss 210966224.0000 USD 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Oci Equity Method Investment After Tax Parent 204444.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20231231 Oci Equity Method Investment After Tax Parent -6852.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Operating Income Loss 1462117051.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 57084593.0000 CNY 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001410578-25-000892 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 5410120.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 11596395.0000 CNY 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001410578-25-000892 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 1588699.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001410578-25-000892 20231231 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 474792.0000 CNY 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001410578-25-000892 20231231 Other Liabilities Noncurrent 1258733.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20241231 Other Liabilities Noncurrent 2143675.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20241231 Other Nonoperating Income Expense -126446.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Other Nonoperating Income Expense 1852235.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Payments To Acquire Property Plant And Equipment 14223115.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Payments To Fund Short Term Loans To Related Parties 826042700.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Prepaid Expense And Other Assets Current 410826.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Prepaid Expense And Other Assets Current 656666733.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20231231 Proceeds From Collection Of Loans Receivable 189752419.0000 CNY 4 us-gaap/2024 Consolidated Entities= Partnership Interest;
0001410578-25-000892 20231231 Proceeds From Sale And Collection Of Loans Receivable 8296900075.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Proceeds From Sale And Collection Of Loans Receivable 483778349.0000 USD 4 us-gaap/2024 Consolidated Entities= Shenzhen Xiaoying Microcredit Co. Ltd.;
0001410578-25-000892 20221231 Proceeds From Short Term Debt 70208800.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Proceeds From Stock Options Exercised 1099619.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Profit Loss 811996439.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Profit Loss 210966225.0000 USD 4 us-gaap/2024 Equity Components= Retained Earnings;
0001410578-25-000892 20221231 Provision For Accounts Receivable And Contract Assets 21835625.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Provision For Deposit Assets Provided During Period -673558.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Provision For Deposit Assets Provided During Period 3222273.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Provision For Loan Losses Expensed -149665.0000 CNY 4 us-gaap/2024 Major Products= Loans;
0001410578-25-000892 20241231 Provision For Loan Losses Expensed 226865598.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20231231 Provision For Loans Receivable During Period And Other Loans 233350276.0000 CNY 4 0001410578-25-000892 Major Products= Xiaoying Credit Loans And Revolving Loans;
0001410578-25-000892 20231231 Retained Earnings Accumulated Deficit 2692018850.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Retained Earnings Accumulated Deficit 571905688.0000 USD 0 us-gaap/2024
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 3562950115.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 158854539.0000 CNY 4 us-gaap/2024 Major Products= Other Services;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 2044343554.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Product Or Service= Guarantee Income;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 4022032.0000 CNY 4 us-gaap/2024 Major Products= Other Loan Products;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Post Origination Service;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 1133314422.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Financial Service;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Post Origination Service;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 3102344942.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 759538640.0000 CNY 4 us-gaap/2024 Product Or Service= Post Origination Service;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 USD 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 USD 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Post Origination Service;
0001410578-25-000892 20221231 Reversal Of Provision For Loan And Lease Losses 6066176.0000 CNY 4 0001410578-25-000892 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20241231 Short Term Borrowings 10000000.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Variable Interest Entities Trusts And Partnerships;
0001410578-25-000892 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3976894961.0000 CNY 0 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 810855877.0000 CNY 0 us-gaap/2024 Equity Components= Retained Earnings;
0001410578-25-000892 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3191193773.0000 CNY 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 4753254692.0000 CNY 0 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 2692018850.0000 CNY 0 us-gaap/2024 Equity Components= Retained Earnings;
0001410578-25-000892 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 9785582.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001410578-25-000892 20221231 Stock Issued During Period Value Stock Options Exercised 277342.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Stock Issued During Period Value Stock Options Exercised 277342.0000 CNY 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20221231 Transfer To Employee Stock Ownership Plans -22144121.0000 CNY 4 0001410578-25-000892 Equity Components= Treasury Stock Common;
0001410578-25-000892 20231231 Transfer To Employee Stock Ownership Plans 37949318.0000 CNY 4 0001410578-25-000892 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20241231 Transfer To Employee Stock Ownership Plans 29193664.0000 CNY 4 0001410578-25-000892 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20241231 Transfer To Employee Stock Ownership Plans 3999516.0000 USD 4 0001410578-25-000892 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20241231 Weighted Average Number Of Shares Outstanding Basic 288828371.0000 shares 4 us-gaap/2024
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 182035610.0000 CNY 0 0001410578-25-000892 Product Or Service= Post Origination Service;
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 278047275.0000 USD 0 0001410578-25-000892
0001410578-25-000892 20241231 Accrual For Taxes Other Than Income Taxes Current And Noncurrent 16396634.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Accrued Income Taxes 174425660.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Variable Interest Entities Trusts And Partnerships;
0001410578-25-000892 20241231 Accrued Income Taxes 23896217.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20231231 Accrued Liabilities And Other Liabilities 604989.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Accrued Liabilities And Other Liabilities 4406921935.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20241231 Accrued Liabilities And Other Liabilities 245607222.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 53537815.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20211231 Allowance For Doubtful Accounts Receivable And Contract Assets 25867957.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20241231 Allowance For Doubtful Accounts Receivable And Contract Assets 3311589.0000 USD 0 0001410578-25-000892 Product Or Service= Credit Losses;
0001410578-25-000892 20231231 Assets 5906955360.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Cash And Cash Equivalents At Carrying Value 1195351730.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Cash And Cash Equivalents At Carrying Value 24753571.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1006959857.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 14280138.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1202355.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 937547718.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect -13077783.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Cash Paid To Institutional Funding Partners 0.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20241231 Cash Payment Received From Consolidated Trusts At Fair Value 232646158.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20241231 Common Stock Value 28331.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Comprehensive Income Net Of Tax 1551481144.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Cost Of Revenue 789300000.0000 CNY 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001410578-25-000892 20241231 Costs And Expenses 547725444.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Deferred Income Taxes And Tax Credits -3733065.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Deferred Income Tax Liabilities Net 65958569.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Deposit Assets Allowance For Credit Losses 2649017.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20241231 Deposit Assets Allowance For Credit Losses 5871290.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20241231 Derivative Assets 0.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level2; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001410578-25-000892 20241231 Dividends Common Stock 57413424.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Dividends Common Stock 7865607.0000 USD 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Dividends Payable Current And Noncurrent 0.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Employee Related Liabilities Current And Noncurrent 94716949.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Equity Method Investment Dividends Or Distributions 7500000.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Financial Investment 608198249.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20211231 Financing Receivable Allowance For Credit Losses 54725057.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20231231 Financing Receivable Allowance For Credit Losses 25854380.0000 USD 0 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 115695330.0000 CNY 0 us-gaap/2024 Financial Instrument= Loans Facilitated In2023; Major Products= Xiaoying Credit Loans And Other Loans;
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 132269818.0000 CNY 0 us-gaap/2024 Financial Instrument= Loans Facilitated In2024; Major Products= Xiaoying Credit Loans And Other Loans;
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 24087327.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 24087327.0000 USD 0 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 0.0000 USD 0 us-gaap/2024 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20231231 General And Administrative Expense 186500000.0000 CNY 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001410578-25-000892 20241231 General And Administrative Expense 24102656.0000 USD 4 us-gaap/2024
0001410578-25-000892 20221231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 1223500000.0000 CNY 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001410578-25-000892 20231231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 1471143931.0000 CNY 4 us-gaap/2024 Geographical= C N;
0001410578-25-000892 20241231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 1894330096.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Income Loss From Equity Method Investments 1190497730.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Income Loss From Equity Method Investments 1547501724.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Income Loss From Financial Investments At Equity Method 30425847.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Income Tax Expense Benefit 55580907.0000 USD 4 us-gaap/2024
0001410578-25-000892 20221231 Increase Decrease From Purchase Of Trading Financial Investment 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Increase Decrease In Accrued Expenses And Other Current Liabilities 92435321.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease In Accrued Expenses And Other Current Liabilities 15747449.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20231231 Increase Decrease In Deposit Payable 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease In Derivative Liabilities 0.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Increase Decrease In Derivative Liabilities 0.0000 USD 4 us-gaap/2024
0001410578-25-000892 20221231 Increase Decrease In Finance Receivables -8088235.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20221231 Increase Decrease In Guarantee Liabilities 14000000.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20221231 Increase Decrease In Prepaid Deferred Expense And Other Assets -121759157.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Increase Decrease In Property And Other Taxes Payable 36144805.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Intangible Assets Net Excluding Goodwill 36591969.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20221231 Interest Paid Net 1991007.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Interest Paid Net 24162853.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Liabilities 5422380668.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20240930 Liabilities 1655731.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001410578-25-000892 20231231 Loans Payable To Institutional Funding Partners 3584040757.0000 CNY 0 0001410578-25-000892 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Loans Payable To Institutional Funding Partners 2184085667.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20231231 Long Term Investments 493411355.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Net Cash Provided By Used In Financing Activities -1935176217.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Net Cash Provided By Used In Investing Activities -1225037957.0000 CNY 4 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Net Cash Provided By Used In Operating Activities 1517583263.0000 CNY 4 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Net Cash Provided By Used In Operating Activities 208703066.0000 USD 4 us-gaap/2024
0001410578-25-000892 20231231 Net Income Loss 458613718.0000 CNY 4 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Net Income Loss 1539905765.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Net Income Loss 494604464.0000 CNY 4 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Oci Equity Method Investment After Tax Parent -313815.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 5410120.0000 CNY 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001410578-25-000892 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 11596395.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 1588699.0000 USD 4 us-gaap/2024
0001410578-25-000892 20221231 Other Noncash Income Expense -658327.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Payments For Proceeds From Loans Receivable 7455098555.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Payments For Proceeds From Loans Receivable 1191317827.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Payments To Acquire Financial Investments 148632843.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Payments To Fund Short Term Loans To Related Parties 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Payments To Fund Short Term Loans To Related Parties 0.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20231231 Prepaid Expense And Other Assets Current 48767987.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Prepaid Expense And Other Assets Current 4668735.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Proceeds From Collection Of Financial Investments 391081258.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20221231 Proceeds From Investors In Consolidated Trusts 98800000.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20221231 Proceeds From Sale And Collection Of Loans Receivable 6263466800.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Proceeds From Sale And Collection Of Loans Receivable 3531243300.0000 CNY 4 us-gaap/2024 Consolidated Entities= Shenzhen Xiaoying Microcredit Co. Ltd.;
0001410578-25-000892 20241231 Proceeds From Sale Of Property Plant And Equipment 107949.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Proceeds From Short Term Debt 802500000.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Profit Loss 1539905765.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Property Plant And Equipment Net 2169179.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Provision For Loan And Leases Losses -4156904.0000 CNY 4 0001410578-25-000892 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20231231 Provision For Loan Losses Expensed -4213234.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20241231 Provision For Loan Losses Expensed -900606.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Revolving Loan;
0001410578-25-000892 20241231 Restricted Cash Allowance For Credit Loss 241398.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20241231 Restricted Cash Current 527457300.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts And Partnerships;
0001410578-25-000892 20241231 Restricted Cash Current Before Allowance Of Credit Losses 92753389.0000 USD 0 0001410578-25-000892
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 437995.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Revolving Loan;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 2815.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Revolving Loan; Product Or Service= Financial Service;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 495092744.0000 CNY 4 us-gaap/2024 Product Or Service= Loan Facilitation Service; Related Party Transactions By Related Party= Related Party;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Loan Products; Product Or Service= Guarantees;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Guarantees;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 4526228336.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 1601289.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Housing Loan; Product Or Service= Financial Service;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 24496658.0000 CNY 4 us-gaap/2024 Product Or Service= Guarantees;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 8081737.0000 CNY 4 us-gaap/2024 Product Or Service= Loan Facilitation Service; Related Party Transactions By Related Party= Related Party;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 315494698.0000 CNY 4 us-gaap/2024 Product Or Service= Service Other;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 425019514.0000 USD 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 27634950.0000 USD 4 us-gaap/2024 Product Or Service= Guarantees;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 104056367.0000 USD 4 us-gaap/2024 Product Or Service= Post Origination Service;
0001410578-25-000892 20221231 Share Based Compensation 53537815.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Stockholders Equity 6953154642.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Stockholders Equity 6953154642.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20211231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 206793.0000 CNY 0 us-gaap/2024 Equity Components= Common Stock;
0001410578-25-000892 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 823550230.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 28331.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001410578-25-000892 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -69820909.0000 USD 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001410578-25-000892 20241231 Stock Issued During Period Value Stock Options Exercised 122507.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Stock Issued During Period Value Stock Options Exercised 16783.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Stock Issued During Period Value Stock Options Exercised 16783.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20241231 Transfer To Employee Stock Ownership Plans -3999516.0000 USD 4 0001410578-25-000892 Equity Components= Treasury Stock Common;
0001410578-25-000892 20231231 Transfer To Employee Stock Ownership Plans In Shares 10661412.0000 shares 4 0001410578-25-000892 Equity Components= Common Stock;
0001410578-25-000892 20241231 Transfer To Employee Stock Ownership Plans In Shares 9327630.0000 shares 4 0001410578-25-000892 Equity Components= Common Stock;
0001410578-25-000892 20221231 Transfer To Investments 0.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Treasury Stock Shares Acquired 52202798.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001410578-25-000892 20231231 Treasury Stock Value Acquired Cost Method 24872828.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Treasury Stock Value Acquired Cost Method 427317136.0000 CNY 4 us-gaap/2024 Equity Components= Treasury Stock Common;
0001410578-25-000892 20241231 Treasury Stock Value Acquired Cost Method 58682021.0000 USD 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Treasury Stock Value Acquired Cost Method 58542208.0000 USD 4 us-gaap/2024 Equity Components= Treasury Stock Common;
0001410578-25-000892 20221231 Unrealized Gain Loss On Derivatives 137654096.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Oci Equity Method Investment After Tax Parent 204444.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 212633162.0000 USD 0 0001410578-25-000892 Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20231231 Accrual For Taxes Other Than Income Taxes Current And Noncurrent 4060878.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20231231 Accrual For Taxes Other Than Income Taxes Current And Noncurrent 126900881.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Variable Interest Entities Trusts And Partnerships;
0001410578-25-000892 20241231 Accrual For Taxes Other Than Income Taxes Current And Noncurrent 119683947.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Variable Interest Entities Trusts And Partnerships;
0001410578-25-000892 20241231 Accrued Liabilities And Other Liabilities 12991042.0000 USD 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20211231 Allowance For Doubtful Accounts Receivable And Contract Assets 8092404.0000 CNY 0 0001410578-25-000892 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20231231 Allowance For Doubtful Accounts Receivable And Contract Assets 9266619.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20230930 Assets 2168301601.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001410578-25-000892 20231231 Assets 4337789740.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Assets 3481797455.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20231231 Cash And Cash Equivalents At Carrying Value 1202355.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Cash And Cash Equivalents At Carrying Value 295277830.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20240930 Cash And Cash Equivalents At Carrying Value 26095749.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001410578-25-000892 20241231 Cash And Cash Equivalents At Carrying Value 1359623.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 164723.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Cash Payment Received From Consolidated Trusts At Fair Value 2497000169.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Changes In Fair Value Of Loans And Payable To Investors 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Commitments And Contingencies CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Common Stock Value 206793.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Common Stock Value 206793.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Comprehensive Income Net Of Tax 869285476.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Cost Of Revenue 2126700000.0000 CNY 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001410578-25-000892 20231231 Cost Of Revenue 1325800000.0000 CNY 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001410578-25-000892 20231231 Costs And Expenses 3352766979.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Deferred Income Taxes And Tax Credits -17565186.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Deferred Income Tax Liabilities Net 642602.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Variable Interest Entities Trusts And Partnerships;
0001410578-25-000892 20231231 Deposits 19700235.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Dividend Income From Financial Investments At Equity Method 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Dividend Income From Financial Investments At Equity Method 0.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20231231 Dividends Common Stock 117627440.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Earnings Per Share Diluted 0.7200 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2599.0000 USD 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Employee Related Liabilities Current And Noncurrent 18482497.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Variable Interest Entities Trusts And Partnerships;
0001410578-25-000892 20241231 Financial Investment 603976478.0000 USD 0 0001410578-25-000892 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20221231 Financing Receivable Allowance For Credit Losses 0.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Revolving Loan;
0001410578-25-000892 20231231 Financing Receivable Allowance For Credit Losses 0.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Revolving Loan;
0001410578-25-000892 20231231 General And Administrative Expense 32600000.0000 CNY 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001410578-25-000892 20221231 Impairment Losses On Financial Investments 8874750.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20221231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 1219896176.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Income Loss From Equity Method Investments -1930792.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Income Tax Expense Benefit 396074046.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Increase Decrease From Collection Of Trading Financial Investment 10238000.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease From Purchase Of Trading Financial Investment 97916010.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease From Purchase Of Trading Financial Investment 13414438.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20221231 Increase Decrease In Deferred Guarantee Income 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease In Deposit Payable -1052679.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease In Deposits To Institutional Co Operators 259047121.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Increase Decrease In Derivative Liabilities -82924152.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Intangible Assets Net Excluding Goodwill 28153262.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20221231 Interest Income Expense Nonoperating Net 3756232.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Interest Income Expense Nonoperating Net 412341.0000 CNY 4 us-gaap/2024 Related Party Transactions By Related Party= Related Party;
0001410578-25-000892 20231231 Interest Paid Net 23247119.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Liabilities 33648051.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Liabilities And Stockholders Equity 986226331.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Loans And Leases Receivables Net Reported Amount 4947833357.0000 CNY 0 0001410578-25-000892 Major Products= Xiaoying Credit Loans And Revolving Loans;
0001410578-25-000892 20231231 Loans Payable To Institutional Funding Partners 3584040757.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20241231 Loans Payable To Institutional Funding Partners 2184085667.0000 CNY 0 0001410578-25-000892 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Loans Payable To Institutional Funding Partners 299218509.0000 USD 0 0001410578-25-000892
0001410578-25-000892 20231231 Net Cash Provided By Used In Financing Activities 1227458379.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Net Cash Provided By Used In Financing Activities -82174565.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Net Cash Provided By Used In Financing Activities -234262887.0000 USD 4 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20231231 Net Cash Provided By Used In Investing Activities 577300000.0000 CNY 4 us-gaap/2024 Restatement= Restatement Adjustment;
0001410578-25-000892 20231231 Net Cash Provided By Used In Investing Activities 1106300000.0000 CNY 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001410578-25-000892 20241231 Net Cash Provided By Used In Investing Activities 307016845.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Net Income Loss 67760534.0000 USD 4 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Net Income Loss Attributable To Noncontrolling Interest 0.0000 USD 4 us-gaap/2024
0001410578-25-000892 20231231 Oci Equity Method Investment After Tax Parent -6852.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Oci Equity Method Investment After Tax Parent -42992.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Operating Income Loss 1873769413.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Other Assets Noncurrent 1560057412.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20231231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 5410120.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Payments Of Dividends 15979547.0000 USD 4 us-gaap/2024
0001410578-25-000892 20231231 Payments To Fund Short Term Loans To Related Parties 70004009.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Payments To Investors In Consolidated Trusts 141288810.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Payments To Investors In Consolidated Trusts 141288810.0000 CNY 4 0001410578-25-000892 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001410578-25-000892 20241231 Prepaid Expense And Other Assets Current 390721.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Proceeds From Collection Of Financial Investments 53577913.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20241231 Provision For Accounts Receivable And Contract Assets 4895282.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20221231 Provision For Deposit Assets Provided During Period 1295879.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20221231 Provision For Loan Losses Expensed 0.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Revolving Loan;
0001410578-25-000892 20241231 Provision For Loan Losses Expensed 31080459.0000 USD 4 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20241231 Provision For Loan Losses Expensed -123383.0000 USD 4 us-gaap/2024 Major Products= Xiaoying Revolving Loan;
0001410578-25-000892 20241231 Provision For Other Credit Losses 21286.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Restricted Cash Current Before Allowance Of Credit Losses 677034809.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20241231 Retained Earnings Accumulated Deficit 571905688.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 7036431.0000 CNY 4 us-gaap/2024 Major Products= Other Loan Products;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 6828467.0000 CNY 4 us-gaap/2024 Major Products= Other Loan Products; Product Or Service= Financial Service;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Financial Service;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 3396621150.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 372015426.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Post Origination Service;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Revolving Loan; Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Revolving Loan; Product Or Service= Service Other;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 966277466.0000 CNY 4 us-gaap/2024 Product Or Service= Financial Service;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 60727604.0000 CNY 4 us-gaap/2024 Product Or Service= Post Origination Service; Related Party Transactions By Related Party= Related Party;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Financial Service;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 30861036.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Service Other;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Housing Loan; Product Or Service= Guarantees;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Housing Loan; Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Housing Loan; Product Or Service= Post Origination Service;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 1137336454.0000 CNY 4 us-gaap/2024 Product Or Service= Financial Service;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 24496658.0000 CNY 4 us-gaap/2024 Product Or Service= Guarantee Income;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 596581987.0000 CNY 4 us-gaap/2024 Product Or Service= Post Origination Service;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 54518856.0000 USD 4 us-gaap/2024 Major Products= Other Services;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 27634950.0000 USD 4 us-gaap/2024 Product Or Service= Guarantee Income;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 425019514.0000 USD 4 us-gaap/2024 Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20231231 Reversal Of Credit Losses For Other Financial Assets 86019.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Reversal Of Credit Losses For Other Financial Assets 155379.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Reversal Of Provision For Loan And Lease Losses 569494.0000 USD 4 0001410578-25-000892 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20241231 Short Term Borrowings 10000000.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Stockholders Equity 952578280.0000 USD 0 us-gaap/2024
0001410578-25-000892 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 206793.0000 CNY 0 us-gaap/2024 Equity Components= Common Stock;
0001410578-25-000892 20221231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest -124596781.0000 CNY 0 us-gaap/2024 Equity Components= Treasury Stock Common;
0001410578-25-000892 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 5847124287.0000 CNY 0 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 29126.0000 USD 0 us-gaap/2024 Equity Components= Common Stock;
0001410578-25-000892 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 6953154642.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 571905688.0000 USD 0 us-gaap/2024 Equity Components= Retained Earnings;
0001410578-25-000892 20221231 Stock Issued During Period Value Stock Options Exercised 277342.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20231231 Transfer To Investments 14342134.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Treasury Stock Value 111520291.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Treasury Stock Value Acquired Cost Method 139813.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20241231 Accrued Income Taxes 174425660.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 40177807.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Allowance For Doubtful Accounts Receivable And Contract Assets 37373243.0000 CNY 0 0001410578-25-000892 Consolidated Entities= Consolidated Trusts And Partnerships;
0001410578-25-000892 20240930 Assets 3145759299.0000 CNY 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Equity Method Investment Nonconsolidated Investee Or Group Of Investees;
0001410578-25-000892 20241231 Assets 1619236036.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Assets 1278667749.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20221231 Borrower Acquisitions And Marketing 833109421.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Cash And Cash Equivalents At Carrying Value 984611409.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Cash And Cash Equivalents At Carrying Value 134891210.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Cash And Cash Equivalents At Carrying Value 186268.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20211231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 992038836.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20211231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 4771477.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 14921021.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect 9508661.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Commitments And Contingencies CNY 0 us-gaap/2024
0001410578-25-000892 20221231 Cost Of Revenue 1337369916.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Deferred Guarantee Income Guarantee Obligations 164724512.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20241231 Deferred Income Tax Assets Net 27086508.0000 USD 0 us-gaap/2024
0001410578-25-000892 20221231 Deferred Income Taxes And Tax Credits 202305809.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Deferred Income Tax Liabilities Net 0.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Deposits 1646242.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Derivative Assets 1038258.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Derivative Assets 1038258.0000 CNY 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001410578-25-000892 20241231 Derivative Assets 142241.0000 USD 0 us-gaap/2024 Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Measurement Frequency= Fair Value Measurements Recurring;
0001410578-25-000892 20241231 Earnings Per Share Basic 5.3300 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2286656.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 944514.0000 USD 4 us-gaap/2024
0001410578-25-000892 20211231 Financing Receivable Allowance For Credit Losses 0.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20221231 Financing Receivable Allowance For Credit Losses 2848327.0000 CNY 0 us-gaap/2024 Major Products= Loans;
0001410578-25-000892 20221231 Financing Receivable Allowance For Credit Losses 0.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 175820629.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Credit Loans And Revolving Loans;
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 0.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Revolving Loan;
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 15850196.0000 USD 0 us-gaap/2024 Financial Instrument= Loans Facilitated In2023; Major Products= Xiaoying Credit Loans And Other Loans;
0001410578-25-000892 20241231 Financing Receivable Allowance For Credit Losses 0.0000 USD 0 us-gaap/2024 Major Products= Loans;
0001410578-25-000892 20231231 Foreign Currency Transaction Gain Loss Before Tax -4023039.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Foreign Currency Transaction Gain Loss Before Tax -1306059.0000 USD 4 us-gaap/2024
0001410578-25-000892 20231231 Gain Loss On Investments 6497518.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Gain Loss On Investments 2347304.0000 USD 4 us-gaap/2024
0001410578-25-000892 20221231 General And Administrative Expense 143234358.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 General And Administrative Expense 175932509.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Guarantees Fair Value Disclosure 0.0000 CNY 0 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20241231 Guarantees Fair Value Disclosure 25706671.0000 USD 0 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20221231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 1243239973.0000 CNY 4 us-gaap/2024 Geographical= C N;
0001410578-25-000892 20241231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments 11787138.0000 CNY 4 us-gaap/2024 Geographical= H K;
0001410578-25-000892 20241231 Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments -1040642.0000 USD 4 us-gaap/2024 Geographical= K Y;
0001410578-25-000892 20231231 Income Loss From Financial Investments At Equity Method -18722720.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Income Loss From Financial Investments At Equity Method 5633191.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20241231 Income Tax Expense Benefit 0.0000 CNY 4 us-gaap/2024 Geographical= H K;
0001410578-25-000892 20231231 Increase Decrease From Collection Of Trading Financial Investment 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease In Deposits To Institutional Co Operators 35489310.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease In Employee Related Liabilities 7946312.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Increase Decrease In Guarantee Liabilities -5613471.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20241231 Increase Decrease In Guarantee Liabilities -15892474.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20241231 Intangible Assets Net Excluding Goodwill 27706487.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Interest Income Expense Nonoperating Net -559693.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Interest Income Expense Nonoperating Net -76678.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Liabilities 2205686086.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20231231 Loans And Leases Receivables Net Reported Amount 3571283174.0000 CNY 0 0001410578-25-000892 Consolidated Entities= Consolidated Trusts And Partnerships; Major Products= Xiaoying Credit Loans And Revolving Loans;
0001410578-25-000892 20241231 Loans And Leases Receivables Net Reported Amount 2916966912.0000 CNY 0 0001410578-25-000892 Consolidated Entities= Consolidated Trusts And Partnerships; Major Products= Xiaoying Credit Loans And Revolving Loans;
0001410578-25-000892 20231231 Net Cash Provided By Used In Financing Activities 814841744.0000 CNY 4 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Net Cash Provided By Used In Financing Activities -40924627.0000 USD 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Net Cash Provided By Used In Investing Activities 913400000.0000 CNY 4 us-gaap/2024 Restatement= Scenario Previously Reported;
0001410578-25-000892 20221231 Net Cash Provided By Used In Operating Activities 451005598.0000 CNY 4 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20221231 Net Income Loss 811996439.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20221231 Net Income Loss 811996439.0000 CNY 4 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Net Income Loss 1186793974.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Net Income Loss 623964980.0000 CNY 4 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20221231 Net Income Loss Attributable To Noncontrolling Interest 0.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Other Assets Noncurrent 55264517.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20231231 Other Assets Noncurrent 22984.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Other Assets Noncurrent 44951464.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Other Assets Noncurrent 413627301.0000 USD 0 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20221231 Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 57084593.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 474792.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 292799.0000 CNY 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001410578-25-000892 20241231 Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax 40113.0000 USD 4 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001410578-25-000892 20241231 Other Liabilities Noncurrent 3769730.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Other Noncash Income Expense 2152467.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Payments For Proceeds From Loans Receivable 2937363564.0000 CNY 4 us-gaap/2024 Consolidated Entities= Shenzhen Xiaoying Microcredit Co. Ltd.; Major Products= Xiaoying Credit Loans And Revolving Loans;
0001410578-25-000892 20241231 Payments For Proceeds From Loans Receivable 8695786212.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Payments For Repurchase Of Common Stock 24872828.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Payments For Repurchase Of Common Stock 24961863.0000 USD 4 us-gaap/2024
0001410578-25-000892 20221231 Payments Of Dividends 0.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Payments To Acquire Financial Investments 20362616.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20231231 Payments To Acquire Property Plant And Equipment 8468350.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Payments To Fund Short Term Loans To Related Parties -25363652.0000 CNY 4 0001410578-25-000892 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Payments To Investors In Consolidated Trusts 0.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20231231 Prepaid Expense And Other Assets Current 25280941.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Prepaid Expense And Other Assets Current 53528.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20221231 Proceeds From Collection Of Loans Earnings Rights From Related Party -100000000.0000 CNY 4 0001410578-25-000892
0001410578-25-000892 20221231 Proceeds From Collection Of Loans Receivable 1089274133.0000 CNY 4 us-gaap/2024 Consolidated Entities= Partnership Interest;
0001410578-25-000892 20241231 Proceeds From Investors In Consolidated Trusts 0.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20241231 Proceeds From Sale And Collection Of Loans Receivable 9360488443.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Proceeds From Sale And Collection Of Loans Receivable 1282381659.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Proceeds From Sale Of Longterm Investments 0.0000 USD 4 us-gaap/2024
0001410578-25-000892 20221231 Proceeds From Sale Of Property Plant And Equipment 5440.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Proceeds From Short Term Debt 18289425.0000 USD 4 us-gaap/2024
0001410578-25-000892 20221231 Proceeds From Stock Options Exercised 277342.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Profit Loss 210966225.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Provision For Contingent Guarantee Liabilities 33117988.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20241231 Provision For Deposit Assets Provided During Period 441450.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20221231 Provision For Loan Losses Expensed -6066176.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20231231 Provision For Loan Losses Expensed 1849982.0000 CNY 4 us-gaap/2024 Major Products= Loans;
0001410578-25-000892 20231231 Provision For Other Credit Losses 86019.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Provision For Other Credit Losses 155379.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Repayments Of Short Term Debt 50689792.0000 USD 4 us-gaap/2024
0001410578-25-000892 20231231 Restricted Cash Allowance For Credit Loss 86019.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20231231 Restricted Cash Current 711756581.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20241231 Restricted Cash Current 527457300.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Trusts;
0001410578-25-000892 20221231 Restricted Cash Current Before Allowance Of Credit Losses 404689250.0000 CNY 0 0001410578-25-000892
0001410578-25-000892 20241231 Retained Earnings Accumulated Deficit 4174511191.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Post Origination Service;
0001410578-25-000892 20221231 Revenue From Contract With Customer Excluding Assessed Tax 158854539.0000 CNY 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Service Other;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 4814884030.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 383611655.0000 CNY 4 us-gaap/2024 Equity Method Investment Nonconsolidated Investee= Consolidated Investee Companies;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 4022032.0000 CNY 4 us-gaap/2024 Major Products= Other Loan Products; Product Or Service= Financial Service;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 2740974233.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 596581987.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Post Origination Service;
0001410578-25-000892 20231231 Revenue From Contract With Customer Excluding Assessed Tax 3288307.0000 CNY 4 us-gaap/2024 Product Or Service= Post Origination Service; Related Party Transactions By Related Party= Related Party;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 5871781746.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Financial Service;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 397949477.0000 CNY 4 us-gaap/2024 Major Products= Other Services; Product Or Service= Service Other;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 5473832269.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 1372004085.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Financial Service;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 38228810.0000 CNY 4 us-gaap/2024 Major Products= Xiaoying Credit Loan; Product Or Service= Service Other;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 201715792.0000 CNY 4 us-gaap/2024 Product Or Service= Guarantees;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 3102344942.0000 CNY 4 us-gaap/2024 Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20241231 Revenue From Contract With Customer Excluding Assessed Tax 0.0000 CNY 4 us-gaap/2024 Product Or Service= Loan Facilitation Service; Related Party Transactions By Related Party= Related Party;
0001410578-25-000892 20241231 Reversal Of Credit Losses For Other Financial Assets 21286.0000 USD 4 0001410578-25-000892
0001410578-25-000892 20241231 Reversal Of Provision For Loan And Lease Losses 4156904.0000 CNY 4 0001410578-25-000892 Major Products= Xiaoying Housing Loan;
0001410578-25-000892 20231231 Short Term Borrowings 320000000.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Variable Interest Entities Trusts And Partnerships;
0001410578-25-000892 20241231 Short Term Borrowings 45004315.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Stockholders Equity 952578280.0000 USD 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20231231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 3196942284.0000 CNY 0 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20241231 Stockholders Equity Including Portion Attributable To Noncontrolling Interest 11104082.0000 USD 0 us-gaap/2024 Equity Components= Accumulated Other Comprehensive Income;
0001410578-25-000892 20231231 Stock Issued During Period Value Stock Options Exercised 1099619.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Transfer Of Investments 51302.0000 USD 4 us-gaap/2024
0001410578-25-000892 20231231 Transfer To Employee Stock Ownership Plans -37949318.0000 CNY 4 0001410578-25-000892 Equity Components= Treasury Stock Common;
0001410578-25-000892 20241231 Transfer To Employee Stock Ownership Plans -29193664.0000 CNY 4 0001410578-25-000892 Equity Components= Treasury Stock Common;
0001410578-25-000892 20221231 Transfer To Employee Stock Ownership Plans In Shares 6889194.0000 shares 4 0001410578-25-000892 Equity Components= Common Stock;
0001410578-25-000892 20241231 Transfer To Investments 0.0000 USD 4 us-gaap/2024
0001410578-25-000892 20241231 Treasury Stock Common Shares 78439504.0000 shares 0 us-gaap/2024
0001410578-25-000892 20221231 Treasury Stock Shares Acquired 48088568.0000 shares 4 us-gaap/2024 Equity Components= Common Stock;
0001410578-25-000892 20221231 Treasury Stock Value Acquired Cost Method 146740902.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Treasury Stock Value Acquired Cost Method 428337679.0000 CNY 4 us-gaap/2024 Equity Components= Parent;
0001410578-25-000892 20241231 Unrealized Gain Loss On Derivatives 1038258.0000 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Weighted Average Number Of Shares Outstanding Basic 288115969.0000 shares 4 us-gaap/2024
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 74750686.0000 CNY 0 0001410578-25-000892 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20221231 Weighted Average Number Of Diluted Shares Outstanding 322403387.0000 shares 4 us-gaap/2024
0001410578-25-000892 20241231 Weighted Average Number Of Diluted Shares Outstanding 293354671.0000 shares 4 us-gaap/2024
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 184648331.0000 CNY 0 0001410578-25-000892 Product Or Service= Guarantee Income;
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 1552073237.0000 CNY 0 0001410578-25-000892 Product Or Service= Loan Facilitation Service;
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 10408395.0000 USD 0 0001410578-25-000892 Product Or Service= Financial Service;
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 25296718.0000 USD 0 0001410578-25-000892 Product Or Service= Guarantee Income;
0001410578-25-000892 20241231 Accounts Receivable And Contract Assets Net 24938776.0000 USD 0 0001410578-25-000892 Product Or Service= Post Origination Service;
0001410578-25-000892 20231231 Accrued Liabilities And Other Liabilities 69989510.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Variable Interest Entities Trusts And Partnerships;
0001410578-25-000892 20231231 Accrued Liabilities And Other Liabilities 69989510.0000 CNY 0 us-gaap/2024 Consolidated Entities= Variable Interest Entities Vies And Consolidated Trust;
0001410578-25-000892 20241231 Accrued Liabilities And Other Liabilities 94825511.0000 CNY 0 us-gaap/2024 Consolidated Entities= Consolidated Variable Interest Entities Trusts And Partnerships;
0001410578-25-000892 20231231 Accumulated Other Comprehensive Income Loss Net Of Tax 69476651.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Additional Paid In Capital 3207028391.0000 CNY 0 us-gaap/2024 Consolidated Entities= Parent Company; Consolidation Items= Reportable Legal Entities;
0001410578-25-000892 20241231 Additional Paid In Capital 439361088.0000 USD 0 us-gaap/2024
0001410578-25-000892 20241231 Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 5504337.0000 USD 4 us-gaap/2024 Equity Components= Additional Paid In Capital;
0001410578-25-000892 20211231 Allowance For Doubtful Accounts Receivable And Contract Assets 0.0000 CNY 0 0001410578-25-000892 Major Products= Loans;
0001410578-25-000892 20221231 Earnings Per Share Basic 2.5700 CNY 4 us-gaap/2024
0001410578-25-000892 20231231 Allowance For Doubtful Accounts Receivable And Contract Assets 54749985.0000 CNY 0 0001410578-25-000892 Consolidated Entities= Consolidated Trusts And Partnerships;
0001410578-25-000892 20231231 Allowance For Doubtful Accounts Receivable And Contract Assets 1096251.0000 CNY 0 0001410578-25-000892 Related Party Transactions By Related Party= Related Party;
0001410578-25-000892 20231231 Assets 11650024640.0000 CNY 0 us-gaap/2024
0001410578-25-000892 20241231 Assets 11819289603.0000 CNY 0 us-gaap/2024

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
ddate The end date for the data value, rounded to the nearest month end.
qtrs The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value.
uom The unit of measure for the value.
segments Tags used to represent axis and member reporting.
coreg If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity.
value The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point.
footnote The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank.

Tags

tag version custom abstract datatype iord crdr tlabel doc
Proceeds From Sale Of Longterm Investments us-gaap/2024 0 0 monetary D D Proceeds from Sale of Long-Term Investments The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, beyond the current operating cycle.
Stock Issued During Period Value Stock Options Exercised us-gaap/2024 0 0 monetary D C Stock Issued During Period, Value, Stock Options Exercised Value of stock issued as a result of the exercise of stock options.
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary I D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Increase Decrease In Other Noncurrent Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Other Noncurrent Assets Amount of increase (decrease) in noncurrent assets classified as other.
Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 0 0 monetary D C Revenue from Contract with Customer, Excluding Assessed Tax Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Increase Decrease In Deferred Guarantee Income 0001410578-25-000892 1 0 monetary D D Increase (Decrease) in Deferred Guarantee Income Amount of increase (decrease) in deferred guarantee income.
Impairment Losses On Financial Investments 0001410578-25-000892 1 0 monetary D D Impairment Losses on Financial Investments Amount of impairment losses on financial investments.
Payments To Acquire Property Plant And Equipment us-gaap/2024 0 0 monetary D C Payments to Acquire Property, Plant, and Equipment The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary I C Equity, Including Portion Attributable to Noncontrolling Interest Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.
Transfer Of Investments us-gaap/2024 0 0 monetary D C Transfer from Investments Value of investments transferred from the entity's investments in noncash transactions.
Payment To Investors Of Consolidated Trusts At Fair Value 0001410578-25-000892 1 0 monetary D C Payment to investors of Consolidated Trusts at fair value It represents payment to investors of consolidated trusts at fair value.
Comprehensive Income Net Of Tax us-gaap/2024 0 0 monetary D C Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D D Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.
Deferred Income Tax Assets Net us-gaap/2024 0 0 monetary I D Deferred Income Tax Assets, Net Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Gain Loss On Investments us-gaap/2024 0 0 monetary D C Gain (Loss) on Investments Amount of realized and unrealized gain (loss) on investment.
Increase Decrease In Property And Other Taxes Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Property and Other Taxes Payable The increase (decrease) during the period in the amount of cash payments due to taxing authorities for non-income-related taxes.
Interest Income Expense Nonoperating Net us-gaap/2024 0 0 monetary D C Interest Income (Expense), Nonoperating Amount of interest income (expense) classified as nonoperating.
Liabilities us-gaap/2024 0 0 monetary I C Liabilities Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.
Liabilities And Stockholders Equity us-gaap/2024 0 0 monetary I C Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Net Income Loss Attributable To Noncontrolling Interest us-gaap/2024 0 0 monetary D D Net Income (Loss) Attributable to Noncontrolling Interest Amount of Net Income (Loss) attributable to noncontrolling interest.
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 0 0 monetary D C OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.
Payments Of Dividends us-gaap/2024 0 0 monetary D C Payments of Dividends Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
Proceeds From Stock Options Exercised us-gaap/2024 0 0 monetary D D Proceeds from Stock Options Exercised Amount of cash inflow from exercise of option under share-based payment arrangement.
Retained Earnings Accumulated Deficit us-gaap/2024 0 0 monetary I C Retained Earnings (Accumulated Deficit) Amount of accumulated undistributed earnings (deficit).
Financial Investments At Amortized Cost 0001410578-25-000892 1 0 monetary I D Financial Investments At Amortized Cost The amount of financial investments at amortized cost.
Proceeds From Collection Of Financial Investments 0001410578-25-000892 1 0 monetary D D Proceeds From Collection Of Financial Investments The cash inflow associated with the collection of financial investments.
Provision For Loan And Leases Losses 0001410578-25-000892 1 0 monetary D D Provision for Loan and Leases Losses Amount of expense related to estimated loss from loan and lease transactions extended
Provision For Other Credit Losses us-gaap/2024 0 0 monetary D D Provision for Other Credit Losses Amount of expense related to credit loss from transactions other than loan and lease transactions.
Additional Paid In Capital us-gaap/2024 0 0 monetary I C Additional Paid in Capital Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.
Common Stock Par Or Stated Value Per Share us-gaap/2024 0 0 perShare I Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock.
Common Stock Shares Outstanding us-gaap/2024 0 0 shares I Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Income Tax Expense Benefit us-gaap/2024 0 0 monetary D D Income Tax Expense (Benefit) Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Increase Decrease In Finance Receivables us-gaap/2024 0 0 monetary D C Increase (Decrease) in Finance Receivables The increase (decrease) during the reporting period in outstanding loans including accrued interest.
Net Income Loss us-gaap/2024 0 0 monetary D C Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Repayments Of Short Term Debt us-gaap/2024 0 0 monetary D C Repayments of Short-Term Debt The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.
Restricted Cash Current us-gaap/2024 0 0 monetary I D Restricted Cash, Current Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.
Stockholders Equity us-gaap/2024 0 0 monetary I C Equity, Attributable to Parent Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
Treasury Stock Value us-gaap/2024 0 0 monetary I D Treasury Stock, Value The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Provision For Loan Losses Expensed us-gaap/2024 0 0 monetary D D Financing Receivable, Credit Loss, Expense (Reversal) Amount of credit loss expense (reversal of expense) for financing receivable.
Proceeds From Investors In Consolidated Trusts 0001410578-25-000892 1 0 monetary D D Proceeds from Investors in Consolidated Trusts The cash inflow associated with cash received from investors in the consolidated trusts.
Provision For Deposit Assets Provided During Period 0001410578-25-000892 1 0 monetary D D Provision For Deposit Assets Provided During The Period Amount Provision created during the period for deposit assets.
Reversal Of Credit Losses For Other Financial Assets 0001410578-25-000892 1 0 monetary D D Reversal of Credit Losses for Other Financial Assets Represents the amount of reversal of credit losses for other financial assets.
Accrued Liabilities And Other Liabilities us-gaap/2024 0 0 monetary I C Accrued Liabilities and Other Liabilities Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.
Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 0 0 monetary I C Accumulated Other Comprehensive Income (Loss), Net of Tax Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.
Assets us-gaap/2024 0 0 monetary I D Assets Amount of asset recognized for present right to economic benefit.
Dividends Payable Current And Noncurrent us-gaap/2024 0 0 monetary I C Dividends Payable Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.
Earnings Per Share Diluted us-gaap/2024 0 0 perShare D Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 0 0 monetary D D Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Employee Related Liabilities Current And Noncurrent us-gaap/2024 0 0 monetary I C Employee-related Liabilities Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
Oci Equity Method Investment After Tax Parent us-gaap/2024 0 0 monetary D C OCI, Equity Method Investment, after Tax, Parent Amount, after tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI, attributable to parent.
Other Assets Noncurrent us-gaap/2024 0 0 monetary I D Other Assets, Noncurrent Amount of noncurrent assets classified as other.
Cost Of Revenue us-gaap/2024 0 0 monetary D D Cost of Revenue The aggregate cost of goods produced and sold and services rendered during the reporting period.
Accounts Receivable And Contract Assets Net 0001410578-25-000892 1 0 monetary I D Accounts Receivable and Contract Assets, Net The amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business, reduced to their estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection and the amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.
Deferred Guarantee Income Guarantee Obligations 0001410578-25-000892 1 0 monetary I C Deferred Guarantee Income, Guarantee Obligations Represents amount of deferred guarantee income associated with guarantee obligations.
Loans And Leases Receivables Net Reported Amount 0001410578-25-000892 1 0 monetary I D Loans And Leases Receivables Net Reported Amount Amount after allowance and deduction of deferred interest and fees, unamortized costs and premiums and discounts from face amounts, of loans and leases held in portfolio, including but not limited to, commercial and consumer loans. Excludes loans and leases covered under loss sharing agreements and loans held for sale.
Dividends Common Stock us-gaap/2024 0 0 monetary D D Dividends, Common Stock Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 0 0 monetary D C Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
Deposits us-gaap/2024 0 0 monetary I C Deposits The aggregate of all deposit liabilities held by the entity, including foreign and domestic, interest and noninterest bearing; may include demand deposits, saving deposits, Negotiable Order of Withdrawal (NOW) and time deposits among others.
Depreciation Depletion And Amortization us-gaap/2024 0 0 monetary D D Depreciation, Depletion and Amortization The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Increase Decrease In Accrued Income Taxes Payable us-gaap/2024 0 0 monetary D D Increase (Decrease) in Income Taxes Payable The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.
Share Based Compensation us-gaap/2024 0 0 monetary D D Share-Based Payment Arrangement, Noncash Expense Amount of noncash expense for share-based payment arrangement.
Accrual For Taxes Other Than Income Taxes Current And Noncurrent us-gaap/2024 0 0 monetary I C Accrual for Taxes Other than Income Taxes Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes.
Allowance For Doubtful Accounts Receivable And Contract Assets 0001410578-25-000892 1 0 monetary I C Allowance for Doubtful Accounts Receivable and Contract Assets For an unclassified balance sheet, a valuation allowance for receivables and contract assets due a company that are expected to be uncollectible.
Changes In Fair Value Of Loans And Payable To Investors 0001410578-25-000892 1 0 monetary D D Changes in Fair value of Loans and Payable to Investors Amount of changes in fair value of loans and payable to investors.
Increase Decrease In Accounts Receivable And Contract Assets 0001410578-25-000892 1 0 monetary D C Increase (Decrease) in Accounts Receivable and Contract Assets The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services and contract assets.
Payments To Investors In Consolidated Trusts 0001410578-25-000892 1 0 monetary D C Payments to Investors in Consolidated Trusts The cash outflow associated with cash paid to investors in the consolidated trusts.
Restricted Cash Allowance For Credit Loss 0001410578-25-000892 1 0 monetary I D Restricted Cash, Allowance for Credit Loss Amount of allowance for credit loss on restricted cash.
Cash And Cash Equivalents At Carrying Value us-gaap/2024 0 0 monetary I D Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Guarantees Fair Value Disclosure us-gaap/2024 0 0 monetary I C Guarantees, Fair Value Disclosure Fair value portion of guarantee, including, but not limited to, financial standby letter of credit, fair value guarantee, guarantee of collection of scheduled contractual cash flows from financial assets, and contracts that contingently require the guarantor to make payments or perform services.
Foreign Currency Transaction Gain Loss Before Tax us-gaap/2024 0 0 monetary D C Gain (Loss), Foreign Currency Transaction, before Tax Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.
Income Taxes Paid Net us-gaap/2024 0 0 monetary D C Income Taxes Paid, Net Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.
Increase Decrease In Employee Related Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Employee Related Liabilities The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 0 0 monetary D C Increase (Decrease) in Prepaid Expense and Other Assets Amount of increase (decrease) in prepaid expenses, and assets classified as other.
Other Noncash Income Expense us-gaap/2024 0 0 monetary D C Other Noncash Income (Expense) Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.
Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 0 0 monetary D D Proceeds from Sale of Property, Plant, and Equipment The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.
Profit Loss us-gaap/2024 0 0 monetary D C Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
Treasury Stock Shares Acquired us-gaap/2024 0 0 shares D Treasury Stock, Shares, Acquired Number of shares that have been repurchased during the period and are being held in treasury.
Increase Decrease From Purchase Of Trading Financial Investment 0001410578-25-000892 1 0 monetary D C Increase (Decrease) From Purchase Of Trading Financial Investment Amount of increase (decrease) from purchase of trading financial investments.
Payments To Fund Short Term Loans To Related Parties 0001410578-25-000892 1 0 monetary D C Payments to Fund Short-term Loans to Related Parties The cash outflow associated with extending a short-term loan to a related party.
Provision For Contingent Guarantee Liabilities 0001410578-25-000892 1 0 monetary D D Provision for Contingent Guarantee Liabilities Amount of expense related to provision for contingent guarantee liabilities.
Transfer To Employee Stock Ownership Plans 0001410578-25-000892 1 0 monetary D D Transfer to Employee Stock Ownership Plans Amount of transfer to employee stock ownership plans.
Long Term Investments us-gaap/2024 0 0 monetary I D Long-Term Investments The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).
Costs And Expenses us-gaap/2024 0 0 monetary D D Costs and Expenses Total costs of sales and operating expenses for the period.
Intangible Assets Net Excluding Goodwill us-gaap/2024 0 0 monetary I D Intangible Assets, Net (Excluding Goodwill) Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
Net Cash Provided By Used In Operating Activities us-gaap/2024 0 0 monetary D Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Operating Income Loss us-gaap/2024 0 0 monetary D C Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues.
Payments For Proceeds From Loans Receivable us-gaap/2024 0 0 monetary D C Payments for (Proceeds from) Loans Receivable The net amount paid or received by the reporting entity associated with purchase (sale or collection) of loans receivable arising from the financing of goods and services.
Other Liabilities Noncurrent us-gaap/2024 0 0 monetary I C Other Liabilities, Noncurrent Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Short Term Borrowings us-gaap/2024 0 0 monetary I C Short-Term Debt Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
Prepaid Expense And Other Assets Current us-gaap/2024 0 0 monetary I D Prepaid Expense and Other Assets, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
General And Administrative Expense us-gaap/2024 0 0 monetary D D General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Borrower Acquisitions And Marketing 0001410578-25-000892 1 0 monetary D D Borrower Acquisitions And Marketing. Expenses relating to borrower acquisitions and marketing.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents After Allowance Of Credit Losses 0001410578-25-000892 1 0 monetary I D Cash, Cash Equivalents, Restricted Cash And Restricted Cash Equivalents, After Allowance of Credit Losses Amount of Cash, Cash Equivalents, Restricted cash and restricted cash equivalents, after allowance of credit losses.
Financial Investment 0001410578-25-000892 1 0 monetary I D Financial Investment Amount of financial investments.
Provision For Accounts Receivable And Contract Assets 0001410578-25-000892 1 0 monetary D D Provision for Accounts Receivable and Contract Assets Amount of expense related to provision for accounts receivable and contract assets.
Restricted Cash Current Before Allowance Of Credit Losses 0001410578-25-000892 1 0 monetary I D Restricted Cash Current Before Allowance of Credit Losses Amount of restricted cash current before allowance of credit losses
Reversal Of Provision For Loan And Lease Losses 0001410578-25-000892 1 0 monetary D C Reversal Of Provision For Loan And Lease Losses Amount of expense related to estimated loss from reversal of provision loan and lease transactions.
Common Stock Value us-gaap/2024 0 0 monetary I C Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Equity Method Investment Dividends Or Distributions us-gaap/2024 0 0 monetary D D Proceeds from Equity Method Investment, Distribution Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.
Financing Receivable Allowance For Credit Losses us-gaap/2024 0 0 monetary I C Financing Receivable, Allowance for Credit Loss Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.
Income Loss From Equity Method Investments us-gaap/2024 0 0 monetary D C Income (Loss) from Equity Method Investments Amount of income (loss) for proportionate share of equity method investee's income (loss).
Transfer To Investments us-gaap/2024 0 0 monetary D D Transfer to Investments Value of investments transferred to the entity's investments in noncash transactions.
Unrealized Gain Loss On Derivatives us-gaap/2024 0 0 monetary D C Unrealized Gain (Loss) on Derivatives The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.
Accrued Income Taxes us-gaap/2024 0 0 monetary I C Accrued Income Taxes Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due. This amount is the total of current and noncurrent accrued income taxes.
Income Loss From Financial Investments At Equity Method 0001410578-25-000892 1 0 monetary D C Income (Loss) From Financial Investments At Equity Method Amount of income (loss) from financial investments at equity method.
Increase Decrease In Deposits To Institutional Co Operators 0001410578-25-000892 1 0 monetary D C Increase Decrease In Deposits To Institutional Co-Operators Amount of increase (decrease) in deposits to institutional co-operators.
Loans Payable To Institutional Funding Partners 0001410578-25-000892 1 0 monetary I C Loans Payable To Institutional Funding Partners Amount of loans payable to institutional funding partners.
Payments To Acquire Financial Investments 0001410578-25-000892 1 0 monetary D C Payments To Acquire Financial Investments The cash outflow associated with the purchase of financial investments during the period.
Proceeds From Collection Of Loans Earnings Rights From Related Party 0001410578-25-000892 1 0 monetary D C Proceeds From Collection Of Loans Earnings Rights From Related Party The cash inflow associated with collection of loans' earnings rights acquired from related party.
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 0 0 monetary D D Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Commitments And Contingencies us-gaap/2024 0 0 monetary I C Commitments and Contingencies Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
Deferred Income Tax Liabilities Net us-gaap/2024 0 0 monetary I C Deferred Income Tax Liabilities, Net Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Gain Loss On Sale Of Property Plant Equipment us-gaap/2024 0 0 monetary D C Gain (Loss) on Disposition of Property Plant Equipment Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.
Interest Paid Net us-gaap/2024 0 0 monetary D C Interest Paid, Excluding Capitalized Interest, Operating Activities Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Net Cash Provided By Used In Financing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Payments For Repurchase Of Common Stock us-gaap/2024 0 0 monetary D C Payments for Repurchase of Common Stock The cash outflow to reacquire common stock during the period.
Proceeds From Sale And Collection Of Loans Receivable us-gaap/2024 0 0 monetary D D Proceeds from Sale and Collection of Loans Receivable The cash inflow associated with the sale and collection of loans receivables arising from the financing of goods and services.
Proceeds From Short Term Debt us-gaap/2024 0 0 monetary D D Proceeds from Short-Term Debt The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.
Deferred Income Taxes And Tax Credits us-gaap/2024 0 0 monetary D D Deferred Income Taxes and Tax Credits Amount of deferred income tax expense (benefit) and income tax credits.
Cash Payment Received From Consolidated Trusts At Fair Value 0001410578-25-000892 1 0 monetary D D Cash Payment Received from Consolidated Trusts at fair value It represents Cash received from investors and institutional funding partners of the consolidated trusts and partnerships at amortized cost.
Deposit Assets Allowance For Credit Losses 0001410578-25-000892 1 0 monetary I C Deposit Assets, Allowance For Credit Losses Amount of allowance for credit loss on deposits.
Increase Decrease In Accrued Expenses And Other Current Liabilities 0001410578-25-000892 1 0 monetary D D Increase (Decrease) in Accrued Expenses and Other Current Liabilities Amount of increase (decrease) in accrued expenses and current liabilities classified as other.
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 0 0 monetary D C APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
Deposit Assets us-gaap/2024 0 0 monetary I D Deposit Assets The carrying amount of the asset transferred to a third party to serve as a deposit, which typically serves as security against failure by the transferor to perform under terms of an agreement.
Derivative Assets us-gaap/2024 0 0 monetary I D Derivative Asset Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.
Earnings Per Share Basic us-gaap/2024 0 0 perShare D Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments us-gaap/2024 0 0 monetary D C Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.
Net Cash Provided By Used In Investing Activities us-gaap/2024 0 0 monetary D D Net Cash Provided by (Used in) Investing Activities Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Other Nonoperating Income Expense us-gaap/2024 0 0 monetary D C Other Nonoperating Income (Expense) Amount of income (expense) related to nonoperating activities, classified as other.
Proceeds From Collection Of Loans Receivable us-gaap/2024 0 0 monetary D D Proceeds from Collection of Loans Receivable The cash inflow associated with the collection, including prepayments, of loans receivable issued for financing of goods and services.
Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 0 0 shares D Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of share options (or share units) exercised during the current period.
Dividend Income From Financial Investments At Equity Method 0001410578-25-000892 1 0 monetary D D Dividend Income from Financial Investments at Equity Method Amount of dividend income from financial investments at equity method.
Increase Decrease In Deposit Payable 0001410578-25-000892 1 0 monetary D D Increase Decrease In Deposit Payable The increase (decrease) during the reporting period in deposit payable.
Increase Decrease In Guarantee Liabilities 0001410578-25-000892 1 0 monetary D D Increase (Decrease) in Guarantee Liabilities The increase (decrease) in guarantee liabilities balances during the period.
Provision For Loans Receivable During Period And Other Loans 0001410578-25-000892 1 0 monetary D D Provision For Loans Receivable During Period And Other Loans Amount of provision for loans receivable during period and other loans.
Increase Decrease In Derivative Liabilities us-gaap/2024 0 0 monetary D D Increase (Decrease) in Derivative Liabilities The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).
Property Plant And Equipment Net us-gaap/2024 0 0 monetary I D Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
Treasury Stock Common Shares us-gaap/2024 0 0 shares I Treasury Stock, Common, Shares Number of previously issued common shares repurchased by the issuing entity and held in treasury.
Treasury Stock Value Acquired Cost Method us-gaap/2024 0 0 monetary D D Treasury Stock, Value, Acquired, Cost Method Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.
Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 0 0 shares D Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Allowance For Doubtful Accounts Financial Investments 0001410578-25-000892 1 0 monetary I C Allowance for Doubtful Accounts Financial Investments For an unclassified balance sheet, a valuation allowance for financial investments due a company that are expected to be uncollectible.
Cash Paid To Institutional Funding Partners 0001410578-25-000892 1 0 monetary D C Cash Paid To Institutional Funding Partners The amount of cash paid to institutional funding partners.
Increase Decrease From Collection Of Trading Financial Investment 0001410578-25-000892 1 0 monetary D D Increase (Decrease) From Collection Of Trading Financial Investment Amount of increase (decrease) from purchase of trading financial investments.
Transfer To Employee Stock Ownership Plans In Shares 0001410578-25-000892 1 0 shares D Transfer to Employee Stock Ownership Plans (in shares) Number of shares that have been transfer to employee stock ownership plans.

Description
Field Name Field Description
tag The unique identifier (name) for a tag in a specific taxonomy release.
version For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined.
custom 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns.
abstract 1 if the tag is not used to represent a numeric fact.
datatype If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag.
iord If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration.
crdr If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL.
tlabel If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here.
doc The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL.

Presentation of Statements

adsh report line stmt inpth rfile tag version plabel negating
0001410578-25-000892 2 8 BS 0 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001410578-25-000892 2 9 BS 0 H Restricted Cash Current us-gaap/2024 Restricted cash, net of allowance for credit losses of RMB86,019 and RMB241,398 as of December 31, 2023 and 2024, respectively (including RMB711,756,581 and RMB527,457,300 from Consolidated Trusts and Partnerships as of December 31, 2023 and 2024, respectively) 0
0001410578-25-000892 2 10 BS 0 H Accounts Receivable And Contract Assets Net 0001410578-25-000892 Accounts receivable and contract assets, net of allowance for credit losses of RMB9,266,619 and RMB24,172,284 as of December 31, 2023 and 2024, respectively (including RMB54,749,985 and RMB37,373,243 from Consolidated Trusts and Partnerships as of December 31, 2023 and 2024, respectively; including RMB1,096,251 and nil from related parties as of December 31, 2023 and 2024, respectively) 0
0001410578-25-000892 2 11 BS 0 H Loans And Leases Receivables Net Reported Amount 0001410578-25-000892 Loan receivable, net 0
0001410578-25-000892 2 12 BS 0 H Deposit Assets us-gaap/2024 Deposits to institutional cooperators, net of allowance for credit losses of RMB2,649,017 and RMB5,871,290 as of December 31, 2023 and 2024, respectively 0
0001410578-25-000892 2 13 BS 0 H Prepaid Expense And Other Assets Current us-gaap/2024 Prepaid expenses and other current assets 0
0001410578-25-000892 2 14 BS 0 H Derivative Assets us-gaap/2024 Financial guarantee derivative 0
0001410578-25-000892 2 15 BS 0 H Deferred Income Tax Assets Net us-gaap/2024 Deferred tax assets, net 0
0001410578-25-000892 2 16 BS 0 H Long Term Investments us-gaap/2024 Long-term investments 0
0001410578-25-000892 2 17 BS 0 H Financial Investment 0001410578-25-000892 Financial investments (amortized cost of RMB406,243,877 and RMB141,685,928 and allowace for credit losses of nil and nil related to investments accounted under AFS model as of December 31, 2023 and 2024, respectively) 0
0001410578-25-000892 2 18 BS 0 H Property Plant And Equipment Net us-gaap/2024 Property and equipment, net 0
0001410578-25-000892 2 19 BS 0 H Intangible Assets Net Excluding Goodwill us-gaap/2024 Intangible assets, net 0
0001410578-25-000892 2 20 BS 0 H Other Assets Noncurrent us-gaap/2024 Other non-current assets 0
0001410578-25-000892 2 21 BS 0 H Assets us-gaap/2024 TOTAL ASSETS 0
0001410578-25-000892 2 23 BS 0 H Loans Payable To Institutional Funding Partners 0001410578-25-000892 Payable to investors and institutional funding partners at amortized cost (including RMB3,584,040,757 and RMB2,184,085,667 from the Consolidated VIEs, Trusts and Partnerships, without recourse to the Company as of December 31, 2023 and 2024, respectively) 0
0001410578-25-000892 2 24 BS 0 H Guarantees Fair Value Disclosure us-gaap/2024 Contingent guarantee liabilities 0
0001410578-25-000892 2 25 BS 0 H Deferred Guarantee Income Guarantee Obligations 0001410578-25-000892 Deferred guarantee income 0
0001410578-25-000892 2 26 BS 0 H Short Term Borrowings us-gaap/2024 Short-term borrowings (including RMB320,000,000 and RMB10,000,000 from the Consolidated VIEs, Trusts and Partnerships, without recourse to the Company as of December 31, 2023 and 2024, respectively) 0
0001410578-25-000892 2 27 BS 0 H Employee Related Liabilities Current And Noncurrent us-gaap/2024 Accrued payroll and welfare (including RMB15,011,080 and RMB18,482,497 from the Consolidated VIEs, Trusts and Partnerships, without recourse to the Company as of December 31, 2023 and 2024, respectively) 0
0001410578-25-000892 2 28 BS 0 H Accrual For Taxes Other Than Income Taxes Current And Noncurrent us-gaap/2024 Other taxes payable (including RMB126,900,881 and RMB119,683,947 from the Consolidated VIEs, Trusts and Partnerships, without recourse to the Company as of December 31, 2023 and 2024, respectively) 0
0001410578-25-000892 2 29 BS 0 H Accrued Income Taxes us-gaap/2024 Income taxes payable (including RMB28,266,791 and RMB174,425,660 from the Consolidated VIEs, Trusts and Partnerships, without recourse to the Company as of December 31, 2023 and 2024, respectively) 0
0001410578-25-000892 2 30 BS 0 H Deposits us-gaap/2024 Deposit payable to channel cooperators 0
0001410578-25-000892 2 31 BS 0 H Dividends Payable Current And Noncurrent us-gaap/2024 Dividend payable 0
0001410578-25-000892 2 32 BS 0 H Accrued Liabilities And Other Liabilities us-gaap/2024 Accrued expenses and other current liabilities (including RMB69,989,510 and RMB94,825,511 from the Consolidated VIEs, Trusts and Partnerships, without recourse to the Company as of December 31, 2023 and 2024, respectively) 0
0001410578-25-000892 2 33 BS 0 H Other Liabilities Noncurrent us-gaap/2024 Other non-current liabilities 0
0001410578-25-000892 2 34 BS 0 H Deferred Income Tax Liabilities Net us-gaap/2024 Deferred tax liabilities (including nil and RMB642,602 from the Consolidated VIEs, Trusts and Partnerships, without recourse to the Company as of December 31, 2023 and 2024, respectively) 0
0001410578-25-000892 2 35 BS 0 H Liabilities us-gaap/2024 TOTAL LIABILITIES 0
0001410578-25-000892 2 36 BS 0 H Commitments And Contingencies us-gaap/2024 Commitments and Contingencies (Note 18) 0
0001410578-25-000892 2 38 BS 0 H Common Stock Value us-gaap/2024 Common shares (US$0.0001 par value; 1,000,000,000 shares authorized as of December 31, 2023 and 2024; 329,117,943 and 329,117,943 shares issued as of December 31, 2023 and 2024; 293,553,607 and 250,678,439 shares outstanding as of December 31, 2023 and 2024) 0
0001410578-25-000892 2 39 BS 0 H Treasury Stock Value us-gaap/2024 Treasury stock (35,564,336 and 78,439,504 shares as of December 31, 2023 and 2024) 1
0001410578-25-000892 2 40 BS 0 H Additional Paid In Capital us-gaap/2024 Additional paid-in capital 0
0001410578-25-000892 2 41 BS 0 H Retained Earnings Accumulated Deficit us-gaap/2024 Retained earnings 0
0001410578-25-000892 2 42 BS 0 H Accumulated Other Comprehensive Income Loss Net Of Tax us-gaap/2024 Other comprehensive income 0
0001410578-25-000892 2 43 BS 0 H Stockholders Equity us-gaap/2024 TOTAL EQUITY 0
0001410578-25-000892 2 44 BS 0 H Liabilities And Stockholders Equity us-gaap/2024 TOTAL LIABILITIES AND EQUITY 0
0001410578-25-000892 3 13 BS 1 H Restricted Cash Allowance For Credit Loss 0001410578-25-000892 Allowance for credit loss on restricted cash 0
0001410578-25-000892 3 14 BS 1 H Restricted Cash Current us-gaap/2024 Restricted cash 0
0001410578-25-000892 3 15 BS 1 H Allowance For Doubtful Accounts Receivable And Contract Assets 0001410578-25-000892 Allowance for doubtful accounts of accounts receivable and contract assets 0
0001410578-25-000892 3 16 BS 1 H Financing Receivable Allowance For Credit Losses us-gaap/2024 Allowance for credit losses on loans receivable 0
0001410578-25-000892 3 17 BS 1 H Loans And Leases Receivables Net Reported Amount 0001410578-25-000892 Loan receivable, net 0
0001410578-25-000892 3 18 BS 1 H Deposit Assets Allowance For Credit Losses 0001410578-25-000892 Allowance for credit loss on deposits 0
0001410578-25-000892 3 20 BS 1 H Financial Investments At Amortized Cost 0001410578-25-000892 Financial investments at amortized cost 0
0001410578-25-000892 3 21 BS 1 H Allowance For Doubtful Accounts Financial Investments 0001410578-25-000892 Allowance for doubtful accounts of financial investments 0
0001410578-25-000892 3 22 BS 1 H Loans Payable To Institutional Funding Partners 0001410578-25-000892 Payable to investors and institutional funding partners at amortized cost 0
0001410578-25-000892 3 23 BS 1 H Short Term Borrowings us-gaap/2024 Total amount of Short-term borrowings 0
0001410578-25-000892 3 24 BS 1 H Employee Related Liabilities Current And Noncurrent us-gaap/2024 Accrued payroll and welfare 0
0001410578-25-000892 3 25 BS 1 H Accrual For Taxes Other Than Income Taxes Current And Noncurrent us-gaap/2024 Other taxes payable 0
0001410578-25-000892 3 26 BS 1 H Accrued Income Taxes us-gaap/2024 Income taxes payable 0
0001410578-25-000892 3 27 BS 1 H Accrued Liabilities And Other Liabilities us-gaap/2024 Accrued expenses and other current liabilities 0
0001410578-25-000892 3 28 BS 1 H Other Liabilities Noncurrent us-gaap/2024 Other non-current liabilities 0
0001410578-25-000892 3 29 BS 1 H Deferred Income Tax Liabilities Net us-gaap/2024 Deferred tax liabilities 0
0001410578-25-000892 3 30 BS 1 H Common Stock Par Or Stated Value Per Share us-gaap/2024 Common shares, par value (in dollars per share) 0
0001410578-25-000892 3 31 BS 1 H Common Stock Shares Authorized us-gaap/2024 Common shares, shares authorized (in shares) 0
0001410578-25-000892 3 32 BS 1 H Common Stock Shares Issued us-gaap/2024 Common shares, shares issued (in shares) 0
0001410578-25-000892 3 33 BS 1 H Common Stock Shares Outstanding us-gaap/2024 Common shares, shares outstanding (in shares) 0
0001410578-25-000892 3 34 BS 1 H Treasury Stock Common Shares us-gaap/2024 Treasury stock, shares 0
0001410578-25-000892 4 15 IS 0 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 Total net revenue 0
0001410578-25-000892 4 17 IS 0 H Cost Of Revenue us-gaap/2024 Origination and servicing 0
0001410578-25-000892 4 18 IS 0 H Borrower Acquisitions And Marketing 0001410578-25-000892 Borrower acquisitions and marketing 0
0001410578-25-000892 4 19 IS 0 H General And Administrative Expense us-gaap/2024 General and administrative 0
0001410578-25-000892 4 21 IS 0 H Provision For Contingent Guarantee Liabilities 0001410578-25-000892 (Reversal of) provision for contingent guarantee liabilities 0
0001410578-25-000892 4 22 IS 0 H Provision For Accounts Receivable And Contract Assets 0001410578-25-000892 Provision for accounts receivable and contract assets 0
0001410578-25-000892 4 23 IS 0 H Provision For Loan And Leases Losses 0001410578-25-000892 Reversal of provision for loan receivable from Xiaoying Housing Loans 0
0001410578-25-000892 4 24 IS 0 H Provision For Loans Receivable During Period And Other Loans 0001410578-25-000892 Provision for loans receivable from Xiaoying Credit Loans and other loans 0
0001410578-25-000892 4 25 IS 0 H Unrealized Gain Loss On Derivatives us-gaap/2024 Change in fair value of financial guarantee derivative 1
0001410578-25-000892 4 26 IS 0 H Changes In Fair Value Of Loans And Payable To Investors 0001410578-25-000892 Fair value adjustments related to Consolidated Trusts 0
0001410578-25-000892 4 27 IS 0 H Provision For Deposit Assets Provided During Period 0001410578-25-000892 Provision for (reversal of) credit losses on deposits to institutional cooperators 0
0001410578-25-000892 4 28 IS 0 H Reversal Of Credit Losses For Other Financial Assets 0001410578-25-000892 (Reversal of) provision for credit losses for other financial assets 0
0001410578-25-000892 4 29 IS 0 H Costs And Expenses us-gaap/2024 Total operating expenses 0
0001410578-25-000892 4 30 IS 0 H Operating Income Loss us-gaap/2024 Income from operations 0
0001410578-25-000892 4 31 IS 0 H Interest Income Expense Nonoperating Net us-gaap/2024 Interest income (expenses), net (including RMB412,341, nil and nil from related parties for the year ended December 31, 2022, 2023 and 2024, respectively) 0
0001410578-25-000892 4 32 IS 0 H Foreign Currency Transaction Gain Loss Before Tax us-gaap/2024 Foreign exchange loss 0
0001410578-25-000892 4 33 IS 0 H Gain Loss On Investments us-gaap/2024 (Loss) income from financial investments 0
0001410578-25-000892 4 34 IS 0 H Impairment Losses On Financial Investments 0001410578-25-000892 Impairment losses on financial investments 1
0001410578-25-000892 4 35 IS 0 H Other Nonoperating Income Expense us-gaap/2024 Other income, net 0
0001410578-25-000892 4 36 IS 0 H Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments us-gaap/2024 Income before income taxes 0
0001410578-25-000892 4 37 IS 0 H Income Tax Expense Benefit us-gaap/2024 Income tax expense 1
0001410578-25-000892 4 38 IS 0 H Income Loss From Equity Method Investments us-gaap/2024 (Loss) gain from equity in affiliates, net of tax 0
0001410578-25-000892 4 39 IS 0 H Income Loss From Financial Investments At Equity Method 0001410578-25-000892 Gain (loss) from financial investments at equity method, net of tax 0
0001410578-25-000892 4 40 IS 0 H Profit Loss us-gaap/2024 Net income 0
0001410578-25-000892 4 41 IS 0 H Net Income Loss Attributable To Noncontrolling Interest us-gaap/2024 Less: net income attributable to non-controlling interests 0
0001410578-25-000892 4 42 IS 0 H Net Income Loss us-gaap/2024 Net income attributable to X Financial 0
0001410578-25-000892 4 44 IS 0 H Oci Equity Method Investment After Tax Parent us-gaap/2024 Gain (loss) from equity in affiliates 0
0001410578-25-000892 4 45 IS 0 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 Income from financial investments 0
0001410578-25-000892 4 46 IS 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation adjustments 0
0001410578-25-000892 4 47 IS 0 H Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Comprehensive income 0
0001410578-25-000892 4 48 IS 0 H Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest us-gaap/2024 Less: comprehensive income attributable to non-controlling interests 0
0001410578-25-000892 4 49 IS 0 H Comprehensive Income Net Of Tax us-gaap/2024 Comprehensive income attributable to X Financial 0
0001410578-25-000892 4 50 IS 0 H Earnings Per Share Basic us-gaap/2024 Net income per share-basic (in dollars per share) 0
0001410578-25-000892 4 51 IS 0 H Weighted Average Number Of Shares Outstanding Basic us-gaap/2024 Weighted average number of ordinary shares outstanding-basic (in shares) 0
0001410578-25-000892 4 52 IS 0 H Earnings Per Share Diluted us-gaap/2024 Net income per share-diluted (in dollars per share) 0
0001410578-25-000892 4 53 IS 0 H Weighted Average Number Of Diluted Shares Outstanding us-gaap/2024 Weighted average number of ordinary shares outstanding-diluted (in shares) 0
0001410578-25-000892 5 10 IS 1 H Revenue From Contract With Customer Excluding Assessed Tax us-gaap/2024 Net revenues 0
0001410578-25-000892 5 11 IS 1 H Interest Income Expense Nonoperating Net us-gaap/2024 Interest income (expenses), net 0
0001410578-25-000892 6 11 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Balance 0
0001410578-25-000892 6 12 EQ 0 H Common Stock Shares Outstanding us-gaap/2024 Balance (in shares) 0
0001410578-25-000892 6 15 EQ 0 H Treasury Stock Value Acquired Cost Method us-gaap/2024 Repurchase of common shares 1
0001410578-25-000892 6 16 EQ 0 H Treasury Stock Shares Acquired us-gaap/2024 Repurchase of common shares (in shares) 1
0001410578-25-000892 6 17 EQ 0 H Transfer To Employee Stock Ownership Plans 0001410578-25-000892 Transfer to employee stock ownership plans 1
0001410578-25-000892 6 18 EQ 0 H Transfer To Employee Stock Ownership Plans In Shares 0001410578-25-000892 Transfer to employee stock ownership plans (in shares) 0
0001410578-25-000892 6 19 EQ 0 H Stock Issued During Period Value Stock Options Exercised us-gaap/2024 Exercise of share option 0
0001410578-25-000892 6 20 EQ 0 H Stock Issued During Period Shares Stock Options Exercised us-gaap/2024 Exercise of share option (in shares) 0
0001410578-25-000892 6 21 EQ 0 H Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value us-gaap/2024 Share-based compensation (Note 16) 0
0001410578-25-000892 6 22 EQ 0 H Profit Loss us-gaap/2024 Net income 0
0001410578-25-000892 6 23 EQ 0 H Oci Equity Method Investment After Tax Parent us-gaap/2024 Gain (loss) from equity in affiliates 0
0001410578-25-000892 6 24 EQ 0 H Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax us-gaap/2024 Income from financial investments 0
0001410578-25-000892 6 25 EQ 0 H Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax us-gaap/2024 Foreign currency translation adjustments 0
0001410578-25-000892 6 26 EQ 0 H Dividends Common Stock us-gaap/2024 Dividend to shareholders 1
0001410578-25-000892 6 27 EQ 0 H Stockholders Equity Including Portion Attributable To Noncontrolling Interest us-gaap/2024 Balance 0
0001410578-25-000892 6 28 EQ 0 H Common Stock Shares Outstanding us-gaap/2024 Balance (in shares) 0
0001410578-25-000892 7 12 CF 0 H Profit Loss us-gaap/2024 Net income 0
0001410578-25-000892 7 14 CF 0 H Depreciation Depletion And Amortization us-gaap/2024 Depreciation and amortization 0
0001410578-25-000892 7 15 CF 0 H Share Based Compensation us-gaap/2024 Share-based compensation 0
0001410578-25-000892 7 16 CF 0 H Impairment Losses On Financial Investments 0001410578-25-000892 Impairment losses on financial investments 0
0001410578-25-000892 7 17 CF 0 H Income Loss From Equity Method Investments us-gaap/2024 Loss (gain) from equity in affiliates, net of tax 1
0001410578-25-000892 7 18 CF 0 H Income Loss From Financial Investments At Equity Method 0001410578-25-000892 (Gain) loss from financial investments at equity method, net of tax 1
0001410578-25-000892 7 19 CF 0 H Equity Method Investment Dividends Or Distributions us-gaap/2024 Dividends from equity in affiliates 0
0001410578-25-000892 7 20 CF 0 H Dividend Income From Financial Investments At Equity Method 0001410578-25-000892 Dividends from financial investments at equity method 0
0001410578-25-000892 7 21 CF 0 H Gain Loss On Sale Of Property Plant Equipment us-gaap/2024 (Gain) loss from disposal of property and equipment 1
0001410578-25-000892 7 22 CF 0 H Gain Loss On Investments us-gaap/2024 Loss (income) from financial investments 1
0001410578-25-000892 7 23 CF 0 H Provision For Accounts Receivable And Contract Assets 0001410578-25-000892 Provision for accounts receivable and contract assets 0
0001410578-25-000892 7 24 CF 0 H Provision For Loan Losses Expensed us-gaap/2024 Provisions for loans receivable from Xiaoying Credit Loans and other loans 0
0001410578-25-000892 7 25 CF 0 H Reversal Of Provision For Loan And Lease Losses 0001410578-25-000892 Reversal of provision for loan receivable from Xiaoying Housing Loans 1
0001410578-25-000892 7 26 CF 0 H Provision For Contingent Guarantee Liabilities 0001410578-25-000892 Provision for contingent guarantee liabilities 0
0001410578-25-000892 7 27 CF 0 H Provision For Deposit Assets Provided During Period 0001410578-25-000892 Provision for (reversal of) credit losses on deposits to institutional cooperators 0
0001410578-25-000892 7 28 CF 0 H Provision For Other Credit Losses us-gaap/2024 (Reversal of) provision for credit losses for other financial assets 0
0001410578-25-000892 7 29 CF 0 H Changes In Fair Value Of Loans And Payable To Investors 0001410578-25-000892 Fair value adjustments related to Consolidated Trusts 0
0001410578-25-000892 7 30 CF 0 H Unrealized Gain Loss On Derivatives us-gaap/2024 Change in fair value of financial guarantee derivative 1
0001410578-25-000892 7 31 CF 0 H Deferred Income Taxes And Tax Credits us-gaap/2024 Deferred tax expenses (benefits) 0
0001410578-25-000892 7 32 CF 0 H Other Noncash Income Expense us-gaap/2024 Other non-cash expenses (income) 1
0001410578-25-000892 7 34 CF 0 H Increase Decrease In Accounts Receivable And Contract Assets 0001410578-25-000892 Accounts receivable and contract assets 1
0001410578-25-000892 7 35 CF 0 H Increase Decrease In Deposits To Institutional Co Operators 0001410578-25-000892 Deposits to institutional cooperators 1
0001410578-25-000892 7 36 CF 0 H Increase Decrease In Prepaid Deferred Expense And Other Assets us-gaap/2024 Prepaid expenses and other current assets 1
0001410578-25-000892 7 37 CF 0 H Increase Decrease In Finance Receivables us-gaap/2024 Loan receivable from Xiaoying Housing Loans 1
0001410578-25-000892 7 38 CF 0 H Increase Decrease From Purchase Of Trading Financial Investment 0001410578-25-000892 Purchase of trading financial investments 1
0001410578-25-000892 7 39 CF 0 H Increase Decrease From Collection Of Trading Financial Investment 0001410578-25-000892 Collection of trading financial investment 0
0001410578-25-000892 7 40 CF 0 H Increase Decrease In Other Noncurrent Assets us-gaap/2024 Other non-current assets 1
0001410578-25-000892 7 41 CF 0 H Increase Decrease In Guarantee Liabilities 0001410578-25-000892 Contingent guarantee liabilities 0
0001410578-25-000892 7 42 CF 0 H Increase Decrease In Deferred Guarantee Income 0001410578-25-000892 Deferred guarantee income 0
0001410578-25-000892 7 43 CF 0 H Increase Decrease In Derivative Liabilities us-gaap/2024 Financial guarantee derivative 0
0001410578-25-000892 7 44 CF 0 H Increase Decrease In Employee Related Liabilities us-gaap/2024 Accrued payroll and welfare 0
0001410578-25-000892 7 45 CF 0 H Increase Decrease In Property And Other Taxes Payable us-gaap/2024 Other taxes payable 0
0001410578-25-000892 7 46 CF 0 H Increase Decrease In Accrued Income Taxes Payable us-gaap/2024 Income taxes payable 0
0001410578-25-000892 7 47 CF 0 H Increase Decrease In Deposit Payable 0001410578-25-000892 Deposit payable to channel cooperators 0
0001410578-25-000892 7 48 CF 0 H Increase Decrease In Accrued Expenses And Other Current Liabilities 0001410578-25-000892 Accrued expenses and other current liabilities 0
0001410578-25-000892 7 49 CF 0 H Net Cash Provided By Used In Operating Activities us-gaap/2024 CASH PROVIDED BY OPERATING ACTIVITIES 0
0001410578-25-000892 7 51 CF 0 H Payments To Acquire Property Plant And Equipment us-gaap/2024 Purchase of property and equipment and intangible assets 1
0001410578-25-000892 7 52 CF 0 H Proceeds From Sale Of Property Plant And Equipment us-gaap/2024 Disposal of property and equipment 0
0001410578-25-000892 7 53 CF 0 H Payments To Acquire Financial Investments 0001410578-25-000892 Purchase of financial investments 1
0001410578-25-000892 7 54 CF 0 H Proceeds From Collection Of Financial Investments 0001410578-25-000892 Collection of financial investments 0
0001410578-25-000892 7 55 CF 0 H Proceeds From Sale Of Longterm Investments us-gaap/2024 Collection of long-term investment 0
0001410578-25-000892 7 56 CF 0 H Payments To Fund Short Term Loans To Related Parties 0001410578-25-000892 Principal payment of loans at fair value 1
0001410578-25-000892 7 57 CF 0 H Proceeds From Collection Of Loans Receivable us-gaap/2024 Principal collection of loans at fair value 0
0001410578-25-000892 7 58 CF 0 H Payments For Proceeds From Loans Receivable us-gaap/2024 Principal payment of loans receivables of the Consolidated Trusts and Partnerships at amortized cost 1
0001410578-25-000892 7 59 CF 0 H Proceeds From Sale And Collection Of Loans Receivable us-gaap/2024 Principal collection of loans receivables of the Consolidated Trusts and Partnerships at amortized cost 0
0001410578-25-000892 7 60 CF 0 H Proceeds From Collection Of Loans Earnings Rights From Related Party 0001410578-25-000892 Collection of loans' earnings rights from related party 1
0001410578-25-000892 7 61 CF 0 H Net Cash Provided By Used In Investing Activities us-gaap/2024 CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES 0
0001410578-25-000892 7 63 CF 0 H Payments For Repurchase Of Common Stock us-gaap/2024 Repurchase of common shares 1
0001410578-25-000892 7 64 CF 0 H Proceeds From Stock Options Exercised us-gaap/2024 Proceeds from exercise of options 0
0001410578-25-000892 7 65 CF 0 H Payments Of Dividends us-gaap/2024 Dividends to shareholders 1
0001410578-25-000892 7 66 CF 0 H Proceeds From Short Term Debt us-gaap/2024 Proceeds from short-term borrowings 0
0001410578-25-000892 7 67 CF 0 H Repayments Of Short Term Debt us-gaap/2024 Repayments of short-term borrowings 1
0001410578-25-000892 7 68 CF 0 H Cash Paid To Institutional Funding Partners 0001410578-25-000892 Cash paid to institutional funding partners 1
0001410578-25-000892 7 69 CF 0 H Proceeds From Investors In Consolidated Trusts 0001410578-25-000892 Cash received from investors of Consolidated Trusts at fair value 0
0001410578-25-000892 7 70 CF 0 H Payments To Investors In Consolidated Trusts 0001410578-25-000892 Cash paid to investors of Consolidated Trusts at fair value 1
0001410578-25-000892 7 71 CF 0 H Cash Payment Received From Consolidated Trusts At Fair Value 0001410578-25-000892 Cash received from investors and institutional funding partners of the Consolidated Trusts and Partnerships at amortized cost 0
0001410578-25-000892 7 72 CF 0 H Payment To Investors Of Consolidated Trusts At Fair Value 0001410578-25-000892 Cash paid to investors and institutional funding partners of the Consolidated Trusts and Partnerships at amortized cost 1
0001410578-25-000892 7 73 CF 0 H Net Cash Provided By Used In Financing Activities us-gaap/2024 CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 0
0001410578-25-000892 7 74 CF 0 H Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 Effect of foreign exchange rate changes 0
0001410578-25-000892 7 75 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect us-gaap/2024 NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH 0
0001410578-25-000892 7 76 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF YEAR 0
0001410578-25-000892 7 77 CF 0 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents us-gaap/2024 CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT YEAR END 0
0001410578-25-000892 7 79 CF 0 H Transfer Of Investments us-gaap/2024 Switch out from VC funds measured at fair value 0
0001410578-25-000892 7 80 CF 0 H Transfer To Investments us-gaap/2024 Switch in VC funds measured at fair value 1
0001410578-25-000892 7 82 CF 0 H Income Taxes Paid Net us-gaap/2024 Income taxes paid, net of refunds 0
0001410578-25-000892 7 83 CF 0 H Interest Paid Net us-gaap/2024 Interest paid for borrowings 0
0001410578-25-000892 8 2 CF 1 H Cash And Cash Equivalents At Carrying Value us-gaap/2024 Cash and cash equivalents 0
0001410578-25-000892 8 3 CF 1 H Restricted Cash Current Before Allowance Of Credit Losses 0001410578-25-000892 Restricted cash 0
0001410578-25-000892 8 4 CF 1 H Restricted Cash Allowance For Credit Loss 0001410578-25-000892 Provision of credit losses for other financial assets 1
0001410578-25-000892 8 5 CF 1 H Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents After Allowance Of Credit Losses 0001410578-25-000892 Total cash and cash equivalents and restricted cash 0

Description
Field Name Field Description
adsh Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission.
report Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site.
line Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived.
stmt The financial statement location to which the value of the “report” field pertains.
inpth Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700.
rfile The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file.
tag The tag chosen by the filer for this line item.
version The taxonomy identifier if the tag is a standard tag, otherwise adsh.
plabel The text presented on the line item, also known as a “preferred” label.
negating Flag to indicate whether the plabel is negating.